{
  "meta": {
    "title": "00363_Late_Night_Pyq_Inicet_Obg-1",
    "url": "https://brainandscalpel.vercel.app/00363-late-night-pyq-inicet-obg-1-f7772db2.html",
    "scrapedAt": "2025-11-29T18:10:38.695Z"
  },
  "questions": [
    {
      "id": 5889,
      "choices": [
        {
          "id": 23526,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breech identified for the first-time during delivery is a contraindication for normal delivery</span></span></span></p>"
        },
        {
          "id": 23527,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breech delivery is done in a hospital where a facility for emergency CS is available</span></span></span></p>"
        },
        {
          "id": 23528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continuous FHR monitoring is required for breech delivery during labor</span></span></span></p>"
        },
        {
          "id": 23529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should be done by a skilled obstetrician</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman in labour presented to the ER. A vaginal breech delivery was planned for her. What statement regarding the management is false?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q6481366",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768898,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Breech identified for the first-time during delivery is a contraindication for normal delivery</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that breech presentation identified for the first time during delivery is a contraindication for normal delivery is false.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breech identified for the first-time during delivery</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is not automatically a contraindication for a vaginal breech delivery. It is crucial to assess the situation carefully, considering the skill of the obstetrician and the facilities available, but it does not universally rule out the possibility of a vaginal breech delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Breech delivery is done in a hospital where a facility for emergency CS is available</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct because the presence of a facility for emergency cesarean section is essential for managing unexpected complications during a breech delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Continuous FHR monitoring is required for breech delivery during labor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct because continuous fetal heart rate monitoring is crucial to detect any signs of fetal distress during a breech delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Should be done by a skilled obstetrician</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is correct as vaginal breech deliveries should be performed by an experienced and skilled obstetrician to manage the potential risks and complications effectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breech presentation identified for the first-time during delivery is not an automatic contraindication for vaginal delivery, provided other criteria are met and facilities are available.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 449, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition.&nbsp;</span></strong></span></span></p>",
      "correct_choice_id": 23526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5801,
      "choices": [
        {
          "id": 23175,
          "text": "<p><span style=\"font-size:12pt;\">A and B</span></p>"
        },
        {
          "id": 23176,
          "text": "<p><span style=\"font-size:12pt;\">B and C</span></p>"
        },
        {
          "id": 23177,
          "text": "<p><span style=\"font-size:12pt;\">A, B and C</span></p>"
        },
        {
          "id": 23178,
          "text": "<p><span style=\"font-size:12pt;\">Only C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements is true regarding the instrument shown below?&nbsp;</span>(INICET MAY 2018)</p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women not on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is removed once the patient starts ambulating.</span></li></ol><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xyXdk3I.jpg\" alt=\"\" width=\"300\" height=\"258\"></span></p>",
      "unique_key": "Q7044685",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768708,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) A, B and C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shows a pneumatic compression hose. It is used in women who are not on any thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\"><strong>It is also used along with pharmacotherapy in women at risk of thromboembolism undergoing a cesarean section</strong></span></li><li><span style=\"font-size:12pt;\">It is discontinued once the patient starts ambulating post-surgery.</span></li><li><span style=\"font-size:12pt;\">It is used because pregnancy and surgery increase the risk of thromboembolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Different guidelines are there for different societies (Both ACOG and SMFM) recommend pneumatic compression devices for all patients undergoing cesarean section. This table is from Williams and shows the different guidelines:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-153951.jpg\" alt=\"\" width=\"1000\" height=\"672\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pneumatic compression devices are used for thromboembolism prevention in women undergoing cesarean sections, whether or not they are on thromboprophylaxis, and are discontinued once the patient starts ambulating post-surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2575, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23177,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5751,
      "choices": [
        {
          "id": 22975,
          "text": "<p><span style=\"font-size:12pt;\">0</span></p>"
        },
        {
          "id": 22976,
          "text": "<p><span style=\"font-size:12pt;\">3</span></p>"
        },
        {
          "id": 22977,
          "text": "<p><span style=\"font-size:12pt;\">5</span></p>"
        },
        {
          "id": 22978,
          "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida came to the labor room at 40 weeks + 5 days gestation for induction of labor. On per vaginal examination, the cervix is less then 1 cm dilated and length is 3 cm. The vertex is at -2 station and the cervix is soft and anterior. What will be the bishop score for this lady?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q2642705",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768906,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop's score, in this case, is 5.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.</span></li><li><span style=\"font-size:12pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.</span></li><li><span style=\"font-size:12pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).</span></li><li><span style=\"font-size:12pt;\">The 5 components of the Modified Bishop score are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/untitled-294.jpg\" alt=\"\" width=\"500\" height=\"272\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_w6olTxi.png\" width=\"1404\" height=\"355\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop score is used to evaluate the readiness of the cervix for induction of labor. A score of 6 or more suggests that the cervix is favorable for induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22977,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5846,
      "choices": [
        {
          "id": 23354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelial cell with bacteria attached on cell surface</span></span></span></p>"
        },
        {
          "id": 23355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bacteria engulfed by macrophages</span></span></span></p>"
        },
        {
          "id": 23356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Neutrophil engulfed bacteria</span></span></span></p>"
        },
        {
          "id": 23357,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bacteria arranged in clusters</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old female presented with a history of profuse vaginal discharge. The discharge has a fishy odour. Which of the following best describes the microscopic finding given below?&nbsp;</span></span>&nbsp;(INICET MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_gCJnA5T.jpg\" style=\"height:252px; width:250px\" /></span></span></span></span></span></p>",
      "unique_key": "Q6518223",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768719,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Epithelial cell with bacteria attached on cell surface</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The microscopic finding described is consistent with &quot;clue cells,&quot; which are a hallmark of bacterial vaginosis (BV). Clue cells are vaginal epithelial cells that are covered with a stippled appearance due to bacteria adhering to their surface. This attachment creates a poorly defined border on the cell. Clue cells are significant in diagnosing bacterial vaginosis because they are a reliable indicator of this condition. For a diagnosis of BV, at least 20 percent of epithelial cells in a wet mount preparation should appear as clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bacteria engulfed by macrophages:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This finding is more indicative of an inflammatory response and is not characteristic of bacterial vaginosis. It is more commonly associated with other types of infections or inflammatory conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neutrophil engulfed bacteria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This description is associated with acute bacterial infections or inflammation but not with bacterial vaginosis, where clue cells are the key finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bacteria arranged in clusters:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While bacteria may be present in clusters in some infections, this description does not specifically identify the clue cells characteristic of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells, which are epithelial cells with bacteria attached on their surface, are the most reliable microscopic indicator of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 554, DC Dutta&rsquo;s Textbook of gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5805,
      "choices": [
        {
          "id": 23191,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystoscopy</span></span></span></p>"
        },
        {
          "id": 23192,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 swab test</span></span></span></p>"
        },
        {
          "id": 23193,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI</span></span></span></p>"
        },
        {
          "id": 91654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystometry</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most useful test in vesicovaginal fistula?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q5596340",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768712,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cystoscopy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystoscopy is the most useful test for diagnosing vesicovaginal fistula (VVF). It allows direct visualization of the bladder and can help identify the exact location, size, and number of fistulas. Additionally, cystoscopy can be used to assess the bladder for any associated injuries or other abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 3 swab test:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This test is used to identify the type of genitourinary fistula (vesicovaginal or ureterovaginal) but is not as specific as cystoscopy for visualizing the fistula directly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. MRI:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While MRI can provide detailed images of the pelvic structures and help in the diagnosis of fistulas, it is not the first-line investigation. It is more useful in complex cases or when additional information is needed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cystometry:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This test evaluates bladder filling and voiding problems and is not specific for diagnosing vesicovaginal fistula.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystoscopy is the most useful test for directly visualizing vesicovaginal fistulas, determining their size, location, and number, and assessing the bladder for any associated injuries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 417, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5806,
      "choices": [
        {
          "id": 23194,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 23195,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trachelectomy</span></span></span></p>"
        },
        {
          "id": 23196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conization</span></span></span></p>"
        },
        {
          "id": 23197,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colposcopy with LEEP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman has cervical intraepithelial neoplasia III. What would be the management?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q1523374",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Colposcopy with LEEP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical intraepithelial neoplasia III (CIN 3) is a severe form of cervical dysplasia that is diagnosed by cervical biopsy. The standard treatment for CIN 2 or CIN 3 is an excisional procedure, which aims to remove the affected tissue to prevent progression to invasive cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LEEP (Loop Electrosurgical Excision Procedure):</span></strong></span></span></li>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LEEP is the excisional procedure of choice for treating CIN 3.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It involves using a thin wire loop that is heated by electric current to excise the transformation zone of the cervix where abnormal cells are located.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LEEP is also known as LLETZ (Large Loop Excision of the Transformation Zone).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a more radical procedure that involves the removal of the uterus. It is generally not the first-line treatment for CIN 3 unless there are other indications, such as concurrent invasive cancer or other gynecological conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Trachelectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This procedure involves removing the cervix while preserving the uterus. It is more commonly used for early-stage cervical cancer in women who wish to preserve fertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Conization:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While conization (removal of a cone-shaped piece of tissue from the cervix) is a valid treatment for CIN 3, LEEP is often preferred due to its effectiveness and lower morbidity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CIN 3 is best treated with an excisional procedure, with the Loop Electrosurgical Excision Procedure (LEEP) being the procedure of choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 328, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23197,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5680,
      "choices": [
        {
          "id": 22692,
          "text": "<p><span style=\"font-size:12pt;\">Hypertension diagnosed at 10 weeks of gestation&nbsp;</span></p>"
        },
        {
          "id": 22693,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic retinopathy</span></p>"
        },
        {
          "id": 22694,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic nephropathy&nbsp;</span></p>"
        },
        {
          "id": 22695,
          "text": "<p><span style=\"font-size:12pt;\">Episode of seizure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pregnant women with which of the following is called systemic hypertension?&nbsp;(INICET MAY 2017) &nbsp; &nbsp; &nbsp; &nbsp;</span></p>",
      "unique_key": "Q1413020",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768657,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hypertension diagnosed at 10 weeks of gestation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is classified as chronic hypertension if it is diagnosed in the first trimester or if hypertension persists beyond 12 weeks postpartum. Hypertension present before pregnancy or diagnosed before the 20th week of gestation also qualifies as chronic hypertension. This is distinct from gestational hypertension, which develops after 20 weeks of gestation in a previously normotensive woman.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic Hypertension:</strong> Defined as blood pressure of ≥ 140/90 mm Hg that was present before pregnancy or diagnosed before the 20th week of gestation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic retinopathy:</strong> This condition is a complication of diabetes affecting the eyes, not a direct indicator of systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diabetic nephropathy:</strong> This is a complication of diabetes that affects the kidneys and can be associated with hypertension, but it is not specific to the definition of systemic hypertension in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Episode of seizure:</strong> Seizures in the context of pregnancy are associated with eclampsia, a severe form of preeclampsia, but do not directly define systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is diagnosed if high blood pressure is present before pregnancy, is diagnosed before 20 weeks of gestation, or persists beyond 12 weeks postpartum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1778, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5880,
      "choices": [
        {
          "id": 23490,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clomiphine citrate</span></span></span></p>"
        },
        {
          "id": 23491,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Letrozole</span></span></span></p>"
        },
        {
          "id": 23492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></span></span></p>"
        },
        {
          "id": 23493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic ovarian drilling</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can be used for the treatment of PCOD except?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q3179558",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768889,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ulipristal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal is not used for the treatment of PCOD. </span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a selective progesterone receptor modulator.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used as an emergency contraceptive and in medical management of fibroids</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clomiphene</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Clomiphene is an anti-estrogen used in ovulation induction in women with PCOS (1<sup>st</sup> line agent) and infertility</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadotropins can also be used in PCOS with infertility in those who have clomiphene resistance (2<sup>nd</sup> line therapy)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Letrozole</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: But nowadays Letrozole (aromatase inhibitor) is the drug for ovulation induction in PCOS with infertility. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Laparoscopic ovarian drilling:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is recommended as second-line therapy in PCOS</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is not used for the treatment of Polycystic Ovary Syndrome (PCOS). It is a selective progesterone receptor modulator primarily used for emergency contraception and managing uterine fibroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 244, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5879,
      "choices": [
        {
          "id": 23486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal movement</span></span></span></p>"
        },
        {
          "id": 23487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal breathing</span></span></span></p>"
        },
        {
          "id": 23488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST</span></span></span></p>"
        },
        {
          "id": 23489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraction stress test</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of fetal biophysical profile?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q1775858",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768888,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Contraction stress test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetal biophysical profile (BPP) is a comprehensive assessment used to evaluate fetal well-being, and it includes five components:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST (Non-Stress Test):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Evaluates fetal heart rate reactivity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniotic Fluid Volume (AFV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Assessed through ultrasound to check the amount of amniotic fluid.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Movement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Observes fetal movements through ultrasound.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Tone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Evaluates the presence of fetal muscle tone and limb movements.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Breathing:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Assesses the presence and duration of fetal breathing movements.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Contraction Stress Test (CST)</strong> is not part of the BPP. Instead, it is a separate test used to assess the fetal heart rate response to uterine contractions, helping to evaluate how well the fetus handles the stress of contractions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fetal movement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a component of the BPP, assessing the number of fetal movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fetal breathing:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a component of the BPP, evaluating the presence of fetal breathing movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. NST:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Non-Stress Test is a key component of the BPP, measuring fetal heart rate reactivity to movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Contraction Stress Test is not a component of the fetal biophysical profile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 122, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition </span></strong></span></span></p>",
      "correct_choice_id": 23489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5800,
      "choices": [
        {
          "id": 23171,
          "text": "<p><span style=\"font-size:12pt;\">FSH</span></p>"
        },
        {
          "id": 23172,
          "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
        },
        {
          "id": 23173,
          "text": "<p><span style=\"font-size:12pt;\">LH</span></p>"
        },
        {
          "id": 23174,
          "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following hormones will be secreted in high amounts by the ovarian granulosa cells during the follicular phase of the menstrual cycle?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q5442340",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768707,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Estrogen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, the granulosa cells of the developing follicles secrete high amounts of estrogen, specifically estradiol. This phase is characterized by the development of a primordial follicle to the Graafian stage, with atresia of neighboring follicles. The following events occur during this phase:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Estrogen Secretion:</strong> Granulosa cells secrete increasing amounts of estrogen, primarily estradiol, which causes proliferation of the endometrium in preparation for potential implantation.</span></li><li><span style=\"font-size:12pt;\"><strong>Up-regulation of Receptors:</strong> LH and FSH receptors are up-regulated in both theca and granulosa cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Feedback Mechanism:</strong> The rising estradiol levels exert a negative feedback effect on the anterior pituitary, suppressing the secretion of FSH and LH to moderate levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. FSH (Follicle Stimulating Hormone):</strong> FSH is secreted by the anterior pituitary gland and stimulates the growth of ovarian follicles but is not secreted by granulosa cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LH (Luteinizing Hormone):</strong> LH is also secreted by the anterior pituitary and plays a role in the later stages of follicle development and ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Progesterone:</strong> Progesterone is primarily secreted by the corpus luteum after ovulation during the luteal phase of the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, ovarian granulosa cells secrete high amounts of estrogen, which is crucial for the proliferation of the endometrium and regulation of FSH and LH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 78, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5793,
      "choices": [
        {
          "id": 23143,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transvaginal ultrasound</span></span></span></p>"
        },
        {
          "id": 23144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassure her that it&#39;s normal to have delayed period</span></span></span></p>"
        },
        {
          "id": 23145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta HCG estimation</span></span></span></p>"
        },
        {
          "id": 23146,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum FSH and LH</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has been on MALA-N for 6 months. She is compliant, but she complained of missed periods. What is the next step?&nbsp;(INICET MAY 2018)</span></span></p>",
      "unique_key": "Q7125282",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768671,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Beta HCG estimation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MALA-N is a combined oral contraceptive pill (OCP). Despite high compliance, all contraceptive methods have a failure rate. The first consideration for a missed period in a woman of reproductive age is pregnancy. Therefore, the next step is to estimate beta HCG levels to rule out pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta HCG Estimation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is essential to confirm or rule out pregnancy. Serum beta HCG can detect pregnancy as early as five days before the first missed period.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Other Options:</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Transvaginal ultrasound:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is not the initial step. It is more appropriate once pregnancy is confirmed or other issues are suspected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Reassure her that it&#39;s normal to have a delayed period:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While some irregularity can occur with OCPs, pregnancy must be ruled out first.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Serum FSH and LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These tests are used to evaluate ovarian function but are not appropriate for initial evaluation of a missed period in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When a woman on combined oral contraceptive pills presents with a missed period, the first step is to rule out pregnancy by estimating beta HCG levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 622, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5764,
      "choices": [
        {
          "id": 23027,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On the action line</span></span></span></p>"
        },
        {
          "id": 23028,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Before the action line</span></span></span></p>"
        },
        {
          "id": 23029,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On the alert line</span></span></span></p>"
        },
        {
          "id": 23030,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After the alert line</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a Partogram, where do you start plotting the cervical dilatation?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q5305038",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) On the alert line</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the WHO modified partograph, labor progression is charted using alert and action lines. The cervical dilatation is plotted starting in the active phase of labor, typically at 4 cm dilation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alert Line</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Represents a cervical dilation rate of 1 cm per hour. The first marking of cervical dilatation should be on this line.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action Line</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plotted 4 hours to the right of the alert line. It indicates when intervention should be considered if labor is not progressing as expected.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. On the action line:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Plotting starts on the alert line, not the action line. The action line is used for intervention planning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Before the action line:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect as the plotting starts on the alert line.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. After the alert line:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect since plotting should start on the alert line.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a Partogram, cervical dilatation is first plotted on the alert line, which indicates the expected rate of progress in labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><a href=\"https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 23029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5803,
      "choices": [
        {
          "id": 23183,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple hysterectomy</span></span></span></p>"
        },
        {
          "id": 23184,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medroxy progesterone acetate</span></span></span></p>"
        },
        {
          "id": 23185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levonorgestrel</span></span></span></p>"
        },
        {
          "id": 23186,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q6425734",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768710,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Simple hysterectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For postmenopausal women with atypical hyperplasia of the endometrium, the recommended treatment is a total hysterectomy. This approach is taken due to the increased risk of progression to endometrial carcinoma, especially given the presence of atypia and the patient&#39;s postmenopausal status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This involves the surgical removal of the uterus and is considered the ideal treatment for postmenopausal women with endometrial hyperplasia with atypia to prevent the progression to cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Medroxyprogesterone acetate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a progestogen treatment used primarily for managing endometrial hyperplasia without atypia, especially in women who desire to preserve fertility. It is not the ideal treatment for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levonorgestrel:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Levonorgestrel intrauterine system (LNG-IUS) is used for managing endometrial hyperplasia without atypia and as a conservative treatment for women wishing to preserve fertility. However, it is not the treatment of choice for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Radiotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is not a standard treatment for endometrial hyperplasia with atypia. It is typically reserved for more advanced or inoperable endometrial cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For postmenopausal women with endometrial hyperplasia with atypia, the ideal treatment is a total hysterectomy to prevent progression to endometrial carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 330, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5682,
      "choices": [
        {
          "id": 22700,
          "text": "<p><span style=\"font-size:12pt;\">Low LH and FSH</span></p>"
        },
        {
          "id": 22701,
          "text": "<p><span style=\"font-size:12pt;\">Low testosterone</span></p>"
        },
        {
          "id": 22702,
          "text": "<p><span style=\"font-size:12pt;\">Oligospermia</span></p>"
        },
        {
          "id": 22703,
          "text": "<p><span style=\"font-size:12pt;\">Low prolactin levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple with 2 children who are not able to conceive for over an year now present to the OPD. The male partner is diagnosed to be having hypogonadotrophic hypogonadism. Which of the following is not true?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q2041323",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768658,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Low prolactin levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hypogonadotropic hypogonadism in males is characterized by a deficiency of gonadotropins (LH and FSH), which leads to low testosterone levels and impaired spermatogenesis. This condition often results in oligospermia or azoospermia, contributing to infertility. Additionally, hypogonadotropic hypogonadism is frequently associated with hyperprolactinemia rather than low prolactin levels.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Low LH and FSH:</strong> Hypogonadotropic hypogonadism is marked by low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) due to inadequate secretion from the pituitary gland.</span></li><li><span style=\"font-size:12pt;\"><strong>Low testosterone:</strong> The low levels of LH lead to reduced stimulation of Leydig cells in the testes, resulting in low testosterone levels.</span></li><li><span style=\"font-size:12pt;\"><strong>Oligospermia:</strong> The low levels of FSH result in impaired spermatogenesis, often leading to oligospermia or azoospermia.</span></li><li><span style=\"font-size:12pt;\"><strong>Low prolactin levels (Incorrect):</strong> Hypogonadotropic hypogonadism is associated with hyperprolactinemia, not low prolactin levels. Elevated prolactin can inhibit the secretion of gonadotropins, further exacerbating the condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Low LH and FSH:</strong> True. Gonadotropin deficiency is a hallmark of hypogonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Low testosterone:</strong> True. The deficiency in LH leads to low testosterone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Oligospermia:</strong> True. The deficiency in FSH leads to impaired spermatogenesis, causing oligospermia or azoospermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A male with hypogonadotropic hypogonadism will have high prolactin levels, low gonadotropins (LH and FSH), low testosterone, and often oligospermia or azoospermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 199, DC Dutta’s Textbook of Gynecology 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5687,
      "choices": [
        {
          "id": 22720,
          "text": "<p><span style=\"font-size:12pt;\">5 cm</span></p>"
        },
        {
          "id": 22721,
          "text": "<p><span style=\"font-size:12pt;\">8 cm</span></p>"
        },
        {
          "id": 22722,
          "text": "<p><span style=\"font-size:12pt;\">4 cm</span></p>"
        },
        {
          "id": 22723,
          "text": "<p><span style=\"font-size:12pt;\">6 cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the latest labour care guidelines, the partogram is plotted in regular intervals after _ cm dilatation:&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q2266234",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768661,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 5 cm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Earlier, in the WHO modified partograph, labor is graphed and analysis includes use of action lines and alert lines.</span></li><li><span style=\"font-size:12pt;\">In this partograph, the plotting starts in active phase (4cm)</span></li><li><span style=\"font-size:12pt;\">The alert line is plotted at a cervical dilatation rate of 1cm/h</span></li><li><span style=\"font-size:12pt;\">The action line is plotted 4h to the right of the alert line</span></li><li><span style=\"background-color:transparent;font-size:12pt;\">&nbsp;The 1st marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">The WHO modified partograph has now been replaced by the WHO labor care guide where the new definition of active labor is 5 cm</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F6uAbxo.png\" width=\"1337\" height=\"340\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As per the WHO modified partograph, plotting is started at 4cm cervical dilatation, and the 1<sup>st</sup> marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">As per the Labor Care Guide, plotting is started at 5 cm cervical dilatation</span></li></ul>",
      "correct_choice_id": 22720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5752,
      "choices": [
        {
          "id": 22979,
          "text": "<p><span style=\"font-size:12pt;\">September 19</span></p>"
        },
        {
          "id": 22980,
          "text": "<p><span style=\"font-size:12pt;\">October 19</span></p>"
        },
        {
          "id": 22981,
          "text": "<p><span style=\"font-size:12pt;\">October 16</span></p>"
        },
        {
          "id": 22982,
          "text": "<p><span style=\"font-size:12pt;\">September 16</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman whose obstetric score is G2 P1 L1 had an LMP of Jan 9th 2017. Calculate the EDD according to Naegele's rule?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q8800268",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768907,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) October 16</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Normal duration of pregnancy: 280 days (40 weeks)</span></li><li><span style=\"font-size:12pt;\">Calculating the EDD: <strong>Naegele’s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Add 9 months + 7 days</span></li><li><span style=\"font-size:12pt;\">Subtract 3 months and add 7 days</span></li><li><span style=\"font-size:12pt;\">For IVF Pregnancies: add 9 months and subtract 7 days from the date of the embryo transfer</span></li></ul></li><li><span style=\"font-size:12pt;\">For e.g. The EDD of this patient will be 16/10/2017.</span></li><li><span style=\"font-size:12pt;\"><strong>Dating the pregnancy:</strong> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">1st trimester CRL: most accurate (till 14 weeks)</span></li><li><span style=\"font-size:12pt;\">BPD in the 2nd trimester</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Naegele's rule is a standard way of calculating the estimated date of delivery by adding 9 months and 7 days to the first day of the last menstrual period. This method assumes a regular 28-day menstrual cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 83, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5796,
      "choices": [
        {
          "id": 23155,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vagina</span></p>"
        },
        {
          "id": 23156,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma vulva</span></p>"
        },
        {
          "id": 23157,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma cervix</span></p>"
        },
        {
          "id": 23158,
          "text": "<p><span style=\"font-size:12pt;\">Carcinoma endometrium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sentinel lymph node biopsy is most useful in which of the following gynecological malignancies?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q5909415",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768703,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Carcinoma vulva</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is particularly useful in the management of vulval carcinomas among gynecological malignancies. The technique helps in determining the extent of lymph node involvement and thereby reduces unnecessary lymph node dissections and their associated complications, such as lymphedema. Sentinel lymph node biopsy can effectively identify the first lymph node (sentinel node) that drains the primary tumor, which is likely to be the first site of metastasis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lymphatic Mapping and Sentinel Node Biopsy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Intraoperative Injection:</strong> Intradermal injection of blue dye around the tumor to map lymphatic drainage.</span></li><li><span style=\"font-size:12pt;\"><strong>Radioactive Tracer:</strong> Labeling tissues with a radioactive tracer and localizing with a hand-held detector.</span></li><li><span style=\"font-size:12pt;\"><strong>Lymphoscintigraphy:</strong> This imaging technique has a 100% detection rate for sentinel lymph nodes.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Utility in Other Malignancies:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breast carcinoma</span></li><li><span style=\"font-size:12pt;\">Penile carcinoma</span></li><li><span style=\"font-size:12pt;\">Malignant melanoma</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Carcinoma vagina:</strong> Sentinel lymph node biopsy is less commonly used in vaginal cancer compared to vulvar cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Carcinoma cervix:</strong> While sentinel lymph node biopsy can be used, it is more established and routinely applied in vulvar cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Carcinoma endometrium:</strong> Sentinel lymph node biopsy is also useful but not as prominently used as in vulvar carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sentinel lymph node biopsy is most useful in vulvar carcinoma among gynecological malignancies to reduce unnecessary lymph node dissection and its complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 608, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5695,
      "choices": [
        {
          "id": 22752,
          "text": "<p><span style=\"font-size:12pt;\">No need additional dose since she is ICT negative</span></p>"
        },
        {
          "id": 22753,
          "text": "<p><span style=\"font-size:12pt;\">Give another dose of Anti-D 72 hour postpartum irrespective of baby blood group</span></p>"
        },
        {
          "id": 22754,
          "text": "<p><span style=\"font-size:12pt;\">Give another dose of Anti-D 72 hour postpartum depending on the baby blood group</span></p>"
        },
        {
          "id": 22755,
          "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Rh negative mother, ICT negative was given Anti D during 28 weeks of pregnancy. Which of the following is the ideal one?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q9690565",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Give another dose of Anti-D 72 hour postpartum depending on the baby blood group</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In Rh-negative women with an Rh-positive partner, Anti-D immunoglobulin prophylaxis is administered to prevent Rh sensitization. If the mother is ICT (Indirect Coombs Test) negative, an initial dose of Anti-D (300 mcg IM) is given at 28 weeks of gestation. Following delivery, an additional dose of Anti-D should be administered within 72 hours if the newborn is Rh-positive. This prevents the mother from forming antibodies against Rh-positive fetal red blood cells that might have entered her circulation during delivery.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Anti-D (300 mcg IM) at 28 weeks:</strong> Given if ICT is negative.</span></li><li><span style=\"font-size:12pt;\"><strong>Postpartum dose within 72 hours:</strong> Required if the baby is Rh-positive. This dose is essential to neutralize any fetal Rh-positive red cells that might have entered the mother's bloodstream during delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. No need for an additional dose since she is ICT negative:</strong> Incorrect. Even if the ICT is negative, an additional dose is necessary postpartum if the baby is Rh-positive to prevent sensitization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Give another dose of Anti-D 72 hours postpartum irrespective of baby blood group:</strong> Incorrect. The postpartum dose is only required if the baby is Rh-positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. All of the above:</strong> Incorrect as not all options are correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Prophylaxis in Rh-negative women with an Rh-positive partner involves giving Anti-D (300 mcg IM) at 28 weeks (if ICT is negative) and repeating the dose within 72 hours after delivery if the baby is Rh-positive.</span></p>",
      "correct_choice_id": 22754,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5715,
      "choices": [
        {
          "id": 22832,
          "text": "<p><span style=\"font-size:12pt;\">Reassure and advice regular follow up once in 6 months</span></p>"
        },
        {
          "id": 22833,
          "text": "<p><span style=\"font-size:12pt;\">Confirm USG findings by ordering CT scan</span></p>"
        },
        {
          "id": 22834,
          "text": "<p><span style=\"font-size:12pt;\">Do an exploratory laparoscopy to visualize the nature of cyst</span></p>"
        },
        {
          "id": 22835,
          "text": "<p><span style=\"font-size:12pt;\">Do CA-125 levels, if normal advise regular check up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old female with history of ovarian carcinoma in the mother achieved menopause with smooth transition. She is on hormone replacement therapy. She developed abdominal pain. On examination, a right adnexal mass was palpable and non-tender. On ultrasound, a 3 X 3 cm smooth cyst in her ovary was noted. What is the next best step?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q7773638",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768670,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Do CA-125 levels, if normal advise regular check up</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The next best step in managing a postmenopausal woman with a small (3 x 3 cm) smooth ovarian cyst is to measure CA-125 levels. CA-125 is a tumor marker used to assess the risk of ovarian cancer, especially in postmenopausal women. Given the benign characteristics of the cyst on ultrasound and the small size, the initial step is to evaluate CA-125 levels:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>CA-125 Levels:</strong> If the CA-125 levels are normal (less than 35), the patient can be advised to have regular follow-ups.</span></li><li><span style=\"font-size:12pt;\"><strong>Regular Follow-ups:</strong> If CA-125 levels are normal, a transvaginal ultrasound (TVS) should be repeated in 6-12 weeks to monitor the cyst. If the cyst persists but remains benign, yearly TVS is recommended.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Reassure and advise regular follow-up once in 6 months:</strong> While reassurance is part of the management, initial evaluation with CA-125 is necessary to rule out malignancy before deciding on the follow-up schedule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Confirm USG findings by ordering a CT scan:</strong> A CT scan is not the first-line investigation for a simple cyst with benign features. Initial evaluation with CA-125 is more appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do an exploratory laparoscopy to visualize the nature of the cyst:</strong> This is invasive and not indicated for a small, benign-appearing cyst without other concerning features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104932.jpg\" alt=\"\" width=\"1000\" height=\"873\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Simple cysts in the post-menopausal age grp:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">≤ 1cm: Considered normal</span></li><li><span style=\"font-size:12pt;\">≤ 5 cm: Ca125; if normal, repeat in 6-12 weeks</span></li><li><span style=\"font-size:12pt;\">&gt; 6 cm: Surgical evaluation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 217, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 22835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5799,
      "choices": [
        {
          "id": 23167,
          "text": "<p><span style=\"font-size:12pt;\">Increased number of theca lutein cysts</span></p>"
        },
        {
          "id": 23168,
          "text": "<p><span style=\"font-size:12pt;\">Persistently enlarged uterus</span></p>"
        },
        {
          "id": 23169,
          "text": "<p><span style=\"font-size:12pt;\">Plateau of high serum hCG</span></p>"
        },
        {
          "id": 23170,
          "text": "<p><span style=\"font-size:12pt;\">Sub-urethral nodule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following can be indicators of choriocarcinoma except:&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4698835",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768706,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Increased number of theca lutein cysts</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Choriocarcinoma is a malignant form of gestational trophoblastic neoplasia (GTN) that arises from trophoblastic tissue following a molar pregnancy, miscarriage, abortion, or normal pregnancy. Indicators of choriocarcinoma include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Persistently enlarged uterus:</strong> Indicates continued trophoblastic proliferation.</span></li><li><span style=\"font-size:12pt;\"><strong>Plateau of high serum hCG:</strong> Persistent high levels of hCG after treatment suggest ongoing trophoblastic disease.</span></li><li><span style=\"font-size:12pt;\"><strong>Sub-urethral nodule:</strong> A rare but specific sign of metastatic choriocarcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of theca lutein cysts alone is not a specific indicator of choriocarcinoma, though these cysts can persist in cases of GTN. The increased number of theca lutein cysts is associated with molar pregnancies and persistent GTN but not specifically indicative of choriocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Persistently enlarged uterus:</strong> This is a common finding in choriocarcinoma due to persistent trophoblastic tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Plateau of high serum hCG:</strong> This is a hallmark of choriocarcinoma as it indicates continued activity of the trophoblastic cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sub-urethral nodule:</strong> This can be a sign of metastasis from choriocarcinoma. Indicates metastasis of choriocarcinoma forming a firm palpable mass beneath urethral nodule</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indicators of choriocarcinoma include persistently enlarged uterus, plateau of high serum hCG, and sub-urethral nodules, but not an increased number of theca lutein cysts alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 361, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10350,
      "choices": [
        {
          "id": 41366,
          "text": "<p><span style=\"font-size:12.0pt;\">90 beats per minute lasting for 60 seconds</span></p>"
        },
        {
          "id": 41367,
          "text": "<p><span style=\"font-size:12.0pt;\">80 beats per minute lasting for 60 seconds</span></p>"
        },
        {
          "id": 41368,
          "text": "<p><span style=\"font-size:12.0pt;\">100 beats per minute lasting for 60 seconds</span></p>"
        },
        {
          "id": 41369,
          "text": "<p><span style=\"font-size:12.0pt;\">70 beats per minute lasting for 60 seconds</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following fits into the criteria of severe variable deceleration, variations less than: (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q6718810",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768917,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 70 beats per minute lasting for 60 seconds</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe variable decelerations in fetal heart rate (FHR) are characterized by a significant reduction in the heart rate below the baseline. The specific criterion for a severe variable deceleration is when the heart rate drops below <strong>70 beats per minute</strong> and this reduction persists for at least <strong>60 seconds</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Variable decelerations</strong> are sudden decreases in the FHR that occur with or without contractions. They are commonly caused by umbilical cord compression, which impedes blood flow through the umbilical vein and arteries, leading to a reduction in fetal cardiac output. This type of deceleration is defined by a decrease of at least 15 beats per minute below the baseline and typically lasts between 15 seconds and less than 2 minutes.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Classification of Variable Decelerations:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mild:</strong> Heart rate decreases to greater than 80 beats per minute regardless of duration, or decelerations lasting less than 30 seconds regardless of the heart rate, or heart rate between 70-80 beats per minute lasting less than 60 seconds.</span></li><li><span style=\"font-size:12pt;\"><strong>Moderate:</strong> Heart rate decreases to more than 70 beats per minute for 30-60 seconds, or heart rate between 70-80 beats per minute lasting more than 60 seconds.</span></li><li><span style=\"font-size:12pt;\"><strong>Severe:</strong> Heart rate decreases to less than 70 beats per minute for an extended duration (at least 60 seconds).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">(70 beats per minute lasting for 60 seconds) meets the criteria for severe variable deceleration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe variable decelerations are defined by a fetal heart rate dropping to less than 70 beats per minute for at least 60 seconds, typically due to umbilical cord compression.</span></p>",
      "correct_choice_id": 41369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5794,
      "choices": [
        {
          "id": 23147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta membranacea</span></span></span></p>"
        },
        {
          "id": 23148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata</span></span></span></p>"
        },
        {
          "id": 23149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Circummarginate placenta</span></span></span></p>"
        },
        {
          "id": 23150,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Circumvallate placenta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman delivered a baby with the normal expulsion of an intact placenta. After half an hour she started bleeding per vaginal. On examination, she was hypotensive, and a boggy mass was palpated per abdomen. Ultrasound showed retained placental tissues. What is the likely diagnosis?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q7236335",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768672,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Placenta succenturiate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is mentioned here that the placenta expelled looked normal and intact</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In such a case, if there is a retained component, it could be a succenturiate lobe </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata refers to a placenta with an additional lobe/lobes of placental tissue located a few centimeters away.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ancillary lobes can be associated with complications such as placenta previa, vasa previa, postpartum hemorrhage or infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture3.jpg\" style=\"height:190px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Placenta membranacea: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta membranacea is a rare placental disorder characterized by the presence of fetal membranes (complete or partially) covered by chorionic villi. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with painless vaginal bleeding in the second and third trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition can be associated with other placental abnormalities, such as placenta previa or accreta.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perinatal outcome may include stillbirth, preterm delivery, or neonatal death.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture4.jpg\" style=\"height:224px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Circummarginate placenta: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncommon&nbsp;variation in placental morphology in which a thin fibrous ring is present at the margin of the chorionic plate where the fetal vessels appear to terminate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The placenta is unduly large and thin. The placenta not only develops from the chorion frondosum but also from the chorion laeve so that the whole of the ovum is practically covered by the placenta</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with Abortion, Hydrorrhea gravidarum (excessive watery vaginal discharge), Antepartum hemorrhage, Growth retardation of the baby, Preterm delivery and Retained placenta or membranes.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture5.jpg\" style=\"height:300px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Circumvallate placenta: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetal surface is divided into a central depressed zone surrounded by a thickened white ring which is usually complete. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ring is situated at varying distances from the margin of the placenta. The ring is composed of a double fold of amnion and chorion with degenerated decidua (vera) and fibrin in between </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vessels radiate from the cord insertion as far as the ring and then disappear from view </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The peripheral zone outside the ring is thicker and the edge is elevated and rounded.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture6.jpg\" style=\"height:252px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata is characterized by an additional lobe of placental tissue separate from the main placenta, which can be retained postpartum, leading to hemorrhage and requiring careful monitoring and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 253, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5691,
      "choices": [
        {
          "id": 22736,
          "text": "<p><span style=\"font-size:12pt;\">Wertheim's hysterectomy</span></p>"
        },
        {
          "id": 22737,
          "text": "<p><span style=\"font-size:12pt;\">Abdominal hysterectomy</span></p>"
        },
        {
          "id": 22738,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal hysterectomy</span></p>"
        },
        {
          "id": 22739,
          "text": "<p><span style=\"font-size:12pt;\">Anterior colporrhaphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which procedure amongst the following has the highest probability of ureteric injury?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q9024930",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Wertheim's hysterectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ureteric injury is most associated with Wertheim's hysterectomy due to the radical nature of the procedure. Wertheim's hysterectomy, also known as radical hysterectomy, involves extensive dissection and removal of not only the uterus but also the surrounding tissues, including the parametria and the upper part of the vagina. This extensive dissection increases the risk of ureteric injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">However, it's important to note that while Wertheim's hysterectomy carries a higher individual risk for ureteric injury due to its radical nature, the most common cause of ureteric injury overall is abdominal hysterectomy, simply because it is the most commonly performed type of hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The overall incidence of ureteric injury in all pelvic operations is about 0.5-1%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Abdominal hysterectomy:</strong> Although it is the most common cause of ureteric injury due to its high frequency, the individual risk per procedure is lower than that of Wertheim's hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Vaginal hysterectomy:</strong> This procedure has a lower risk of ureteric injury compared to abdominal and Wertheim's hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anterior colporrhaphy:</strong> This procedure, which is used to repair the anterior vaginal wall, has a much lower risk of ureteric injury compared to hysterectomy procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ureteric injury is most associated with Wertheim's hysterectomy due to the extensive dissection involved in the procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The risk of ureteric injury is highest with a radical hysterectomy followed laparoscopic or robotic hysterectomy followed by abdominal hysterectomy and least risk is with vaginal hysterectomy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: TeLinde’s Operative gynecology 12<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5761,
      "choices": [
        {
          "id": 23015,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low MSAFP, high hCG, low UE3</span></span></span></p>"
        },
        {
          "id": 23016,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High MSAFP, low hCG, high UE3</span></span></span></p>"
        },
        {
          "id": 23017,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low MSAFP, high hCG, high UE3</span></span></span></p>"
        },
        {
          "id": 23018,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High MSAFP, low hCG, low UE3</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman has a fetus with Down&#39;s syndrome. Triple test done at 15-16 weeks will have?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9975201",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768913,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Low MSAFP, high hCG, low UE3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The triple and quadruple test is done between 15 &ndash; 21 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of Triple test are: Free &beta; hCG, unconjugated Estriol (uE3) and Maternal Serum &alpha;-fetoprotein.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the Quadruple test are: Free &beta; hCG, unconjugated Estriol (uE3), Maternal Serum &alpha;-fetoprotein. And Inhibin A.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/untitled-296.jpg\" style=\"height:146px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">*Easy to remember: <strong>B</strong> for <strong>B</strong>ig; so in Down&rsquo;s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The triple test results for Down&#39;s syndrome typically show low MSAFP, high hCG, and low uE3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 859, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23015,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5712,
      "choices": [
        {
          "id": 22820,
          "text": "<p><span style=\"font-size:12pt;\">Conization</span></p>"
        },
        {
          "id": 22821,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 22822,
          "text": "<p><span style=\"font-size:12pt;\">Repeat Colposcopy and biopsy after 6 months</span></p>"
        },
        {
          "id": 22823,
          "text": "<p><span style=\"font-size:12pt;\">HPV DNA testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female came for routine PAP smear testing. The report came as HSIL. On colposcopy and biopsy, it was confirmed to be carcinoma in situ. What is the next step?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q5274902",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768669,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Conization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Carcinoma in situ (CIS) of the cervix is classified as Stage 0 cancer. In a young woman with stage 0 cervical cancer, the management of choice is conization. Conization involves the removal of a cone-shaped section of the cervix, including the transformation zone and part of the endocervix. This procedure serves both diagnostic and therapeutic purposes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diagnostic:</strong> Conization provides a tissue specimen for histopathological examination, which is more definitive compared to a cytological specimen obtained from a Pap smear.</span></li><li><span style=\"font-size:12pt;\"><strong>Therapeutic:</strong> If the histopathology shows clear margins, conization can be curative for carcinoma in situ.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysterectomy:</strong> This is a more radical treatment and is generally reserved for cases where there is invasive cancer or other indications. It is not the first-line treatment for CIS in a young woman.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Repeat colposcopy and biopsy after 6 months:</strong> In the case of confirmed carcinoma in situ, conization is preferred. There is no need of repeat colpobiopsy&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. HPV DNA testing:</strong> This test is used for screening and risk assessment but is not a treatment for confirmed carcinoma in situ.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Conization, which involves the removal of a cone-shaped section of the cervix including the transformation zone and part of the endocervix, is the management of choice for carcinoma in situ in young women. It is both diagnostic and therapeutic if histopathology shows clear margins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture2_ByHlD4H.jpg\" alt=\"\" width=\"500\" height=\"354\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 992, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 22820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5887,
      "choices": [
        {
          "id": 23518,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous, singleton, cephalic, induced labour</span></span></span></p>"
        },
        {
          "id": 23519,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous, singleton, cephalic, spontaneous labour</span></span></span></p>"
        },
        {
          "id": 23520,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparous without previous CS, spontaneous labour</span></span></span></p>"
        },
        {
          "id": 23521,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparous without previous CS, induced/CS before labour</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Modified Robson&#39;s classification class 1 includes:&nbsp;</span></span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q8673487",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768896,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Nulliparous, singleton, cephalic, spontaneous labour</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class 1 of the Modified Robson&#39;s classification specifically includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A woman who has never given birth before.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Singleton</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A pregnancy involving only one fetus.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The fetal presentation is head-down.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ge;37 weeks</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The pregnancy is at or beyond 37 weeks of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Labour onset is spontaneous, not induced or via cesarean section.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This classification is used to categorize pregnant women for analyzing obstetric outcomes, interventions, and cesarean section rates. The Modified Robson&rsquo;s classification is a system developed by the World Health Organization to help in understanding and comparing cesarean section rates and labor outcomes across different settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-227.jpg\" style=\"height:570px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robson&rsquo;s 10 groups</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Nulliparous, singleton, cephalic, induced labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 2 of the Modified Robson&#39;s classification, which includes nulliparous women with a singleton cephalic fetus who are &ge;37 weeks and have induced labor or a cesarean section before labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Multiparous without previous CS, spontaneous labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 3 of the Modified Robson&#39;s classification, which includes multiparous women (without previous cesarean section) with a singleton cephalic fetus who are &ge;37 weeks and are in spontaneous labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Multiparous without previous CS, induced/CS before labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 4 of the Modified Robson&#39;s classification, which includes multiparous women (without previous cesarean section) with a singleton cephalic fetus who are &ge;37 weeks and have induced labor or a cesarean section before labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class 1 of the Modified Robson&#39;s classification includes nulliparous women with a singleton cephalic fetus who are &ge;37 weeks and are in spontaneous labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://iris.who.int/bitstream/handle/10665/259512/9789241513197-eng.pdf?sequence=1\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://iris.who.int/bitstream/handle/10665/259512/9789241513197-eng.pdf?sequence=1</strong></a></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "correct_choice_id": 23519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5678,
      "choices": [
        {
          "id": 22684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus</span></span></span></p>"
        },
        {
          "id": 22685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bulbospongiosus</span></span></span></p>"
        },
        {
          "id": 22686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ischiocavernosus </span></span></span></p>"
        },
        {
          "id": 22687,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superficial transverse perineal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The deepest part of perineal body injury, which causes cystocele, enterocoele and urethral descent is?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q6453522",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768656,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pubococcygeus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pubococcygeus is the deepest part of the levator ani muscle. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Injury to it can cause enterocele, cystocele, and urethral descent.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The levator ani muscles are the most important muscles in the pelvic floor and maintain a constant state of contraction. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weakening of this muscle decreases support for the vagina, bladder, uterus, or rectum or alter the position of the neck of the bladder and urethra.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bulbospongiosus, Option C. ischiocavernosus&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. superficial transverse perineal</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are all superficial muscles and their damage does not result in uterovaginal descent</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supports of the vagal have been described by Delancey as shown below and defects in these lead to different levels of uterovaginal prolapse</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in Level 1 support: Vaginal apical prolapse and uterine prolapse</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 2 support: Cystocele and Rectocele</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in level 3 support: urethrocele and deficient perineal body</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-174103.jpg\" style=\"height:427px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 544, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5797,
      "choices": [
        {
          "id": 23159,
          "text": "<p><span style=\"font-size:12pt;\">Uterotonic within 1 minute of delivery</span></p>"
        },
        {
          "id": 23160,
          "text": "<p><span style=\"font-size:12pt;\">Delayed clamping, cutting and ligation of cord</span></p>"
        },
        {
          "id": 23161,
          "text": "<p><span style=\"font-size:12pt;\">Gentle massage of uterus</span></p>"
        },
        {
          "id": 23162,
          "text": "<p><span style=\"font-size:12pt;\">Controlled cord traction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the active management of the third stage of labor to prevent post-partum hemorrhage?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q9399000",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768704,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Gentle massage of uterus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>AMTSL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Purpose</strong>: To prevent <strong>postpartum hemorrhage (PPH)</strong>, a major cause of maternal death.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Give a uterotonic drug</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Oxytocin 10 IU IM</strong> immediately after the birth of the baby</span></li><li><span style=\"font-size:16px;\">This helps the uterus contract and reduce bleeding</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Controlled Cord Traction (CCT)</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Gently pull the umbilical cord while supporting the uterus to help deliver the placenta</span></li><li><span style=\"font-size:16px;\">Only if trained and placenta is ready to come</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Intermittent uterine tone assessment</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Delayed cord clamping</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Wait 1–3 minutes before clamping the umbilical cord</span></li><li><span style=\"font-size:16px;\">Improves baby’s iron stores and reduces anemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Uterotonic within 1 minute of delivery:</strong> This is a critical step in AMTSL to prevent PPH by promoting uterine contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Delayed clamping, cutting and ligation of cord:</strong> Delayed cord clamping (after 1 to 3 minutes) is recommended for all births to enhance neonatal outcomes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Controlled cord traction:</strong> This is a part of AMTSL to aid in the delivery of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The active management of the third stage of labor includes the administration of a uterotonic, controlled cord traction, and assessing uterine tone rather than sustained uterine massage for all women who have received a uterotonic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1\"><span style=\"font-size:16px;\"><strong><u>https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1</u></strong></span></a></p>",
      "correct_choice_id": 23161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5683,
      "choices": [
        {
          "id": 22704,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></span></span></p>"
        },
        {
          "id": 22705,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 19, 23, 33, 45, 58</span></span></span></p>"
        },
        {
          "id": 22706,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></span></span></p>"
        },
        {
          "id": 22707,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV Nonavalent vaccine is active against which of the following serotypes?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q9810511",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768659,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV Vaccines available are</span></span></span>:</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervarix (Bivalent): 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervavac (India&rsquo;s indigenous HPV vaccine): Quadrivalent: 6, 11, 16, 18</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardasil 9 is a nonavalent HPV vaccine effective against 9 serotypes of the virus </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These include: 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><a href=\"https://www.merckvaccines.com/gardasil9/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://www.merckvaccines.com/gardasil9/</span></strong></a></span></span></p>",
      "correct_choice_id": 22707,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5742,
      "choices": [
        {
          "id": 22940,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conisation</span></span></span></p>"
        },
        {
          "id": 22941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryotherapy</span></span></span></p>"
        },
        {
          "id": 22942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Targeted biopsy</span></span></span></p>"
        },
        {
          "id": 22943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q1181897",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768904,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Targeted biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A targeted biopsy (punch biopsy) is the next line of management in the above case as the patient is symptomatic (postcoital bleeding) and has a visible lesion. This approach allows for the direct sampling of the lesion to assess for malignancy or other pathological changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Conisation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Conisation is an excisional procedure that is typically performed once biopsy-proven cervical intraepithelial neoplasia (CIN 2 and 3) is diagnosed. It is not the initial step for a visible mass with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cryotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cryotherapy is an ablative procedure used for treating CIN1 or 2. It is not suitable for initial diagnosis or for lesions suspected of being malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pap smear:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A Pap smear is done when there are symptoms with no identifiable lesion. It is a screening tool and not diagnostic for a visible lesion with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a symptomatic patient with a visible cervical lesion and postcoital bleeding, a targeted biopsy is the appropriate next step to obtain a definitive diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 327, DC Dutta&rsquo;a Textbook of gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5847,
      "choices": [
        {
          "id": 23358,
          "text": "<p><span style=\"font-size:12pt;\">VIA</span></p>"
        },
        {
          "id": 23359,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿VILI</span></p>"
        },
        {
          "id": 23360,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿PAP smear</span></p>"
        },
        {
          "id": 23361,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Colposcopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following instrument is used for……:&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xZqzTuR.jpg\" alt=\"\" width=\"300\" height=\"51\"></span></p>",
      "unique_key": "Q2624712",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768720,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) PAP smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shown is that of Ayre's spatula which is used for preparing PAP smear.</span></li><li><span style=\"font-size:12pt;\">It is used to scrape the squamocolumnar junction of the cervix while preparing a Pap smear.</span></li><li><span style=\"font-size:12pt;\">A cytobrush is used to take endocervical samples</span></li><li><span style=\"font-size:12pt;\">The smear is fixed with 95% ethanol</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. VIA</strong>: This is Visual Inspection under Acetic Acid. This is done by applying acetic acid on the cervix. Any acetowhite area is suspicious for dysplasia. It is done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. VILI</strong>: Visual inspection under Lugol Iodine: This is done by applying Lugol’s iodine on the cervix. A dysplastic area will not take up iodine. It is also done in low resource settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-175609.png\" alt=\"\" width=\"500\" height=\"440\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Colposcopy</strong>: This is a magnified view of the cervix. It is done in patients with abnormal pap smear/ HPV +Ve/ VIA +ve or VILI +ve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ayre's spatula is used for preparing a Pap smear by scraping cells from the cervix for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 325, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5758,
      "choices": [
        {
          "id": 23003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysgerminoma</span></span></span></p>"
        },
        {
          "id": 23004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endodermal sinus tumor</span></span></span></p>"
        },
        {
          "id": 23005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant teratoma</span></span></span></p>"
        },
        {
          "id": 23006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucinous cystadenocarcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old female patient presents with an ovarian mass. On further evaluation, her serum biomarkers are found to be normal except for LDH, which is found to be elevated. The most likely diagnosis is:&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q3613268",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768912,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dysgerminoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical history of a 16-year-old female presenting with an ovarian mass with raised LDH points towards the diagnosis of dysgerminoma. Dysgerminomas usually arise in young women or in children, with an average incidence at the age of 20. They currently account for approximately one-third of all malignant ovarian germ cell tumors and are the most common malignant ovarian tumors found in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endodermal sinus tumor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is typically associated with elevated alpha-fetoprotein (AFP), not LDH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Malignant teratoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This type of tumor does not typically present with elevated LDH as the sole abnormal marker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mucinous cystadenocarcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This epithelial ovarian tumor is usually associated with elevated CA-125, not LDH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysgerminoma is the most likely diagnosis in a young female with an ovarian mass and elevated LDH levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 381, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5859,
      "choices": [
        {
          "id": 23406,
          "text": "<p><span style=\"font-size:12pt;\">I</span></p>"
        },
        {
          "id": 23407,
          "text": "<p><span style=\"font-size:12pt;\">II</span></p>"
        },
        {
          "id": 23408,
          "text": "<p><span style=\"font-size:12pt;\">III</span></p>"
        },
        {
          "id": 23409,
          "text": "<p><span style=\"font-size:12pt;\">IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A case of gestational trophoblastic neoplasm is detected to have metastasis in the lungs. It is considered as stage?</span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q2982475",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) III</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gestational trophoblastic neoplasms (GTN) are classified into stages based on their extent of spread:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Stage I</strong>: The disease is confined to the uterus.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage II</strong>: The disease has spread outside the uterus but remains confined to the genital structures.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage III</strong>: The disease has metastasized to the lungs, which is a significant indicator of progression beyond the local genital structures.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage IV</strong>: The disease has spread to other distant sites beyond the lungs, such as the liver or brain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Since the case involves metastasis specifically to the lungs, it falls into <strong>Stage III</strong>, which is characterized by such pulmonary involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Metastasis to the lungs in gestational trophoblastic neoplasm is classified as Stage III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 364, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5688,
      "choices": [
        {
          "id": 22724,
          "text": "<p><span style=\"font-size:12pt;\">Thinning of corpus callosum</span></p>"
        },
        {
          "id": 22725,
          "text": "<p><span style=\"font-size:12pt;\">Microcephaly</span></p>"
        },
        {
          "id": 22726,
          "text": "<p><span style=\"font-size:12pt;\">Holoprosencephaly</span></p>"
        },
        {
          "id": 22727,
          "text": "<p><span style=\"font-size:12pt;\">Macrocephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In fetal alcohol syndrome, which of the following is not seen?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q1722472",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768662,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Macrocephaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fetal alcohol syndrome (FAS) is associated with various structural, behavioral, and developmental anomalies due to prenatal alcohol exposure. One of the key features of FAS is microcephaly, not macrocephaly. High levels of alcohol ingestion during pregnancy can severely impact embryonic and fetal development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of at least one of the following characteristics is indicative of fetal alcohol syndrome:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Growth restriction:</strong> Can occur before and/or after birth.</span></li><li><span style=\"font-size:12pt;\"><strong>Facial anomalies:</strong> These include small palpebral fissures, indistinct or absent philtrum, epicanthic folds, flattened nasal bridge, short length of nose, thin upper lip, low-set and unparallel ears, and retarded midfacial development.</span></li><li><span style=\"font-size:12pt;\"><strong>CNS dysfunction:</strong> Includes microcephaly, mental retardation, and abnormal neurobehavioral development such as attention deficit with hyperactivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Other features that may be seen in FAS include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Incomplete holoprosencephaly:</strong> A condition where the forebrain does not completely divide into two hemispheres.</span></li><li><span style=\"font-size:12pt;\"><strong>Agenesis of the corpus callosum and cerebellar vermis:</strong> Developmental anomalies where these brain structures are partially or completely absent.</span></li><li><span style=\"font-size:12pt;\"><strong>Cardiac anomalies:</strong> Such as ventricular septal defect (VSD), atrial septal defect (ASD), and tetralogy of Fallot.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Macrocephaly</strong> is not seen in fetal alcohol syndrome; instead, microcephaly is characteristic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Thinning of corpus callosum:</strong> This is a characteristic finding in fetal alcohol syndrome due to developmental anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Microcephaly:</strong> This is commonly seen in fetal alcohol syndrome and is one of the diagnostic features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Holoprosencephaly:</strong> Incomplete holoprosencephaly can be seen in fetal alcohol syndrome as a result of severe midline developmental anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fetal alcohol syndrome is associated with microcephaly, not macrocephaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 397, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5857,
      "choices": [
        {
          "id": 23398,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal hysterectomy</span></p>"
        },
        {
          "id": 23399,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Cesarean section</span></p>"
        },
        {
          "id": 23400,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Manchester operation</span></p>"
        },
        {
          "id": 23401,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fothergill's surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The given instrument is used in:</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_Bj2rK4w.jpg\" alt=\"\" width=\"300\" height=\"142\"></span></p>",
      "unique_key": "Q7906196",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768885,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The instrument shown is a <strong>Doyen's retractor</strong>, which is specifically used in cesarean sections. It plays a crucial role during the surgical procedure by retracting the bladder to provide proper exposure of the lower uterine segment. This retraction helps in ensuring a clear view and access to the uterus while minimizing the risk of bladder injury. The Doyen's retractor is used once the utero-vesical fold of peritoneum is opened and the bladder is dissected away from the lower uterine segment. It holds the bladder away from the site of the uterine incision, facilitating a safer and more efficient cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Vaginal hysterectomy:</strong> Involves the removal of the uterus through the vaginal canal and typically uses different types of retractors and instruments designed for vaginal access, not the Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Manchester operation:</strong> This is a surgical procedure used to correct uterovaginal prolapse and does not involve the use of Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fothergill's surgery:</strong> This is performed for uterovaginal prolapse and uses different instruments tailored for vaginal repairs, not the Doyen's retractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Doyen's retractor is used during cesarean sections to retract the bladder and prevent bladder injury while providing exposure of the lower uterine segment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 751, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5730,
      "choices": [
        {
          "id": 22892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascending aorta syndrome</span></span></span></p>"
        },
        {
          "id": 22893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Superior vena-caval syndrome</span></span></span></p>"
        },
        {
          "id": 22894,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Abdominal aorta syndrome</span></span></span></p>"
        },
        {
          "id": 22895,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Supine vena cava syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant lady with PIH was being monitored with bed rest in supine position. Which of the following is a complication of the below representation?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2017-1.jpg\" style=\"height:149px; width:300px\" /></p>",
      "unique_key": "Q6824729",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768899,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Supine vena cava syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image illustrates supine hypotension syndrome, also known as supine vena cava syndrome. This condition occurs in the third trimester of pregnancy when the gravid uterus compresses the inferior vena cava (IVC) while the woman is in a supine position. This compression leads to reduced venous return to the heart, causing hypotension, tachycardia, and syncope. It is especially dangerous during cesarean sections, as spinal anesthesia can exacerbate hypotension. To prevent this, a wedge is placed beneath the right hip during the procedure to tilt the patient slightly to the left, thereby relieving pressure on the vena cava.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ascending aorta syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition is not typically associated with pregnancy and does not involve the pressure of the gravid uterus on the IVC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Superior vena-caval syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This syndrome involves obstruction of the superior vena cava, leading to symptoms such as facial swelling and dyspnea. It is unrelated to the position of a pregnant woman and the compression of the IVC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Abdominal aorta syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: There is no specific syndrome by this name. The abdominal aorta may be compressed during pregnancy, but it does not lead to the symptoms associated with supine hypotension syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supine vena cava syndrome occurs in the third trimester of pregnancy due to the pressure of the gravid uterus on the inferior vena cava when the woman is in a supine position, leading to hypotension, tachycardia, and syncope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2237, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22895,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5884,
      "choices": [
        {
          "id": 23506,
          "text": "<p><span style=\"font-size:12pt;\">Right occipito-posterior</span></p>"
        },
        {
          "id": 23507,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Left occipito-anterior</span></p>"
        },
        {
          "id": 23508,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Left occipito-posterior</span></p>"
        },
        {
          "id": 23509,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Right occipito-anterior</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the fetal position in the given image?&nbsp;</span>(INICET MAY 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-may-2020-3.jpg\" alt=\"\" width=\"250\" height=\"347\"></p>",
      "unique_key": "Q3921915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768893,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Right occipito-anterior</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>Right occipito-anterior</strong> (ROA) position means the fetal occiput (the back of the head) is directed towards the mother's right side and anterior (towards the front of the pelvis). This position indicates that the fetus is facing towards the mother's right side with its back towards the front of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In fetal positions:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Right occipito-anterior (ROA)</strong>: The occiput is on the right side and anteriorly towards the front of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Left occipito-anterior (LOA)</strong>: The occiput is on the left side and anteriorly towards the front of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Right occipito-posterior (ROP)</strong>: The occiput is on the right side but posteriorly towards the back of the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Left occipito-posterior (LOP)</strong>: The occiput is on the left side but posteriorly towards the back of the pelvis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Right occipito-posterior</strong>: This position indicates that the occiput is on the right side but towards the back of the pelvis, not the front.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Left occipito-anterior</strong>: This position indicates that the occiput is on the left side and anteriorly towards the front of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Left occipito-posterior</strong>: This position indicates that the occiput is on the left side but towards the back of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the Right occipito-anterior (ROA) position, the fetal occiput is directed towards the mother's right side and the anterior part of the pelvis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 89, DC Ditta’s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23509,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5878,
      "choices": [
        {
          "id": 23482,
          "text": "<p><span style=\"font-size:12pt;\">Spiegelberg criteria</span></p>"
        },
        {
          "id": 23483,
          "text": "<p><span style=\"font-size:12pt;\">Rubin criteria</span></p>"
        },
        {
          "id": 23484,
          "text": "<p><span style=\"font-size:12pt;\">Studdiford criteria</span></p>"
        },
        {
          "id": 23485,
          "text": "<p><span style=\"font-size:12pt;\">Ring of fire</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following criteria is used for diagnosing abdominal pregnancy?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q2186458",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768887,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Studdiford criteria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\"><strong>Studdiford Criteria</strong> is for diagnosis of Primary abdominal pregnancy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Both tubes and ovaries normal with no marks of injury</span></li><li><span style=\"font-size:12pt;\">Utero-peritoneal fistula should not be seen</span></li><li><span style=\"font-size:12pt;\">The placenta should be attached exclusively to the peritoneal surface</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Spiegelberg Criteria:&nbsp;</strong>Spiegelberg Criteria is for Ovarian ectopic</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tube on the affected side must be intact</span></li><li><span style=\"font-size:12pt;\">The gestation sac must occupy the position of the ovary</span></li><li><span style=\"font-size:12pt;\">The gestation sac in the ovary must be connected to the uterus by the ovarian ligament</span></li><li><span style=\"font-size:12pt;\">Definite ovarian tissue must be found in the sac wall on histopathology</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Rubin criteria</strong>: Rubin criteria is for Cervical pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ring of fire</strong>: Ring of fire is a sign seen on USG-Color doppler in an unruptured tubal ectopic</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Studdiford Criteria</strong> are used to diagnose primary abdominal pregnancy. This criterion involves:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Ensuring that both fallopian tubes and ovaries are normal with no signs of injury.</span></li><li><span style=\"font-size:12pt;\">Confirming that no utero-peritoneal fistula is present.</span></li><li><span style=\"font-size:12pt;\">Verifying that the placenta is attached exclusively to the peritoneal surface.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These criteria help distinguish primary abdominal pregnancy from other types of ectopic pregnancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 219, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5810,
      "choices": [
        {
          "id": 23210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At the onset of labor</span></span></span></p>"
        },
        {
          "id": 23211,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">34 weeks</span></span></span></p>"
        },
        {
          "id": 23212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36 weeks</span></span></span></p>"
        },
        {
          "id": 23213,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">40 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q8889904",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768717,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 36 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of anticoagulation in pregnant women with cardiac disease involves switching from warfarin to heparin at specific times to minimize the risk of complications to the fetus and to prepare for delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to Heparin at 36 Weeks:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> According to guidelines from the American College of Chest Physicians, pregnant women on warfarin therapy should switch to heparin at 36 weeks of gestation. This is done to reduce the risk of bleeding complications during labor and delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guidelines Summary:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early Pregnancy (up to 12 weeks):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue warfarin as soon as pregnancy is diagnosed, especially if the warfarin dose is &gt;5mg/day, due to the risk of warfarin embryopathy.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replace with heparin (5,000 units twice daily subcutaneously) or low molecular weight heparin (LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 12 Weeks to 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin can be resumed after the 12th week and continued up to 36 weeks.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch from warfarin to heparin (either unfractionated or LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Just Before Delivery:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue heparin just before delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restart heparin (unfractionated or LMWH) 6 hours after vaginal delivery and 24 hours after cesarean section.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin therapy can also be safely resumed during breastfeeding.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The final switch from warfarin to heparin in pregnant women with cardiac disease is advised at 36 weeks of gestation to minimize the risk of bleeding complications during labor and delivery.</span></span></span></p>",
      "correct_choice_id": 23212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5734,
      "choices": [
        {
          "id": 22908,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Do a routine episiotomy</span></span></span></p>"
        },
        {
          "id": 22909,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual support to perineum to maintain flexion of head</span></span></span></p>"
        },
        {
          "id": 22910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Never give warm compress to the perineum</span></span></span></p>"
        },
        {
          "id": 22911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform labor in lithotomy position</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is part of the WHO guidelines for the management of second stage of labor?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q4767393",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768901,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Manual support to perineum to maintain flexion of head</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The WHO Recommendations 2018 for the intrapartum second stage of labor emphasize the importance of a positive birth experience. The guidelines suggest manual support to the perineum to maintain the flexion of the fetal head, which helps in reducing perineal trauma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WHO Recommendations 2018 (Intrapartum Second Stage):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recommended:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duration of the second stage in primigravida: up to 3 hours; in multigravida: up to 2 hours</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allowing the birthing position of choice</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encouraging the mother to follow her own urge to push</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reducing perineal trauma by using techniques such as hands-on guarding, warm compresses, and perineal massage</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not recommended:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Routine episiotomy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fundal pressure</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Do a routine episiotomy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not recommended as a routine practice according to WHO guidelines. Episiotomy should only be performed when clinically indicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Never give warm compress to the perineum</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect. Warm compresses to the perineum are recommended to help reduce perineal trauma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Perform labor in lithotomy position</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The WHO guidelines recommend allowing the woman to choose her birthing position, rather than mandating the lithotomy position.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual support to the perineum and maintaining the flexion of the fetal head are part of the WHO recommendations for the second stage of labor to reduce perineal trauma and ensure a positive birth experience.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><a href=\"https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 22909,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5852,
      "choices": [
        {
          "id": 23378,
          "text": "<p><span style=\"font-size:12pt;\">Deceleration</span></p>"
        },
        {
          "id": 23379,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Acceleration</span></p>"
        },
        {
          "id": 23380,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Normal</span></p>"
        },
        {
          "id": 23381,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Deceleration followed by acceleration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does this Cardio-Tocography show?&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_LB2EmwO.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p>",
      "unique_key": "Q3801571",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768722,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Deceleration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Cardio-Tocography (CTG) in question shows decelerations, which are characterized by a drop in the fetal heart rate (FHR) by at least 15 beats per minute (bpm) lasting for at least 15 seconds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Types of Decelerations on CTG:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Early Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction.</span></li><li><span style=\"font-size:12pt;\">Caused by head compression during contractions.</span></li><li><span style=\"font-size:12pt;\">Commonly observed in the second stage of labor.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Late Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir of the deceleration occurs after the peak of the contraction.</span></li><li><span style=\"font-size:12pt;\">Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia.</span></li><li><span style=\"font-size:12pt;\">Considered an ominous sign and requires prompt evaluation and intervention.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Variable Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">There is no fixed relationship between the deceleration and uterine contractions.</span></li><li><span style=\"font-size:12pt;\">Caused by umbilical cord compression, often seen with oligohydramnios.</span></li><li><span style=\"font-size:12pt;\">Significant if persistent, with FHR &lt;70 bpm for more than 60 seconds.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prolonged Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes.</span></li><li><span style=\"font-size:12pt;\">May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Acceleration:</strong> This would show an increase in the fetal heart rate by at least 15 bpm lasting for at least 15 seconds, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal:</strong> A normal CTG would not show any decelerations or would show a typical pattern of fetal heart rate variability and accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deceleration followed by acceleration:</strong> This pattern would indicate a combination of deceleration and acceleration, which is not specified here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Decelerations on a Cardio-Tocography indicate a decrease in fetal heart rate by at least 15 bpm lasting for at least 15 seconds, with different types signifying various conditions and levels of concern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 994, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5855,
      "choices": [
        {
          "id": 23390,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CMV</span></span></span></p>"
        },
        {
          "id": 23391,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus</span></span></span></p>"
        },
        {
          "id": 23392,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxoplasma</span></span></span></p>"
        },
        {
          "id": 23393,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is the cause of Hydrops fetalis?&nbsp;</span></span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q7900777",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768884,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Parvovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis. (Non immune hydrops)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 infects fetal erythroid progenitor cells and causes anemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe anemia leads to high-output cardiac failure and hydrops fetalis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. CMV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Typically causes peri-ventricular calcifications in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Toxoplasmosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Causes:&nbsp; hydrocephalus, chorioretinitis, cerebral calcification, microcephaly, seizures and mental retardation in the newborn.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. HIV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vertical transmission of HIV from mother to infant can occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis due to its effect on fetal erythroid progenitor cells, leading to severe anemia and subsequent high-output cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 347, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5849,
      "choices": [
        {
          "id": 23366,
          "text": "<p><span style=\"font-size:12pt;\">Amniocentesis at 16 weeks</span></p>"
        },
        {
          "id": 23367,
          "text": "<p><span style=\"font-size:12pt;\">Manual removal of placenta</span></p>"
        },
        {
          "id": 23368,
          "text": "<p><span style=\"font-size:12pt;\">Intrauterine transfusion at 28 weeks</span></p>"
        },
        {
          "id": 23369,
          "text": "<p><span style=\"font-size:12pt;\">MTP at 63 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anti-D vaccine is not given in which of the following conditions?&nbsp;</span>(INICET MAY 2019)</p>",
      "unique_key": "Q8374705",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768721,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Intrauterine transfusion at 28 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Anti-D vaccine (anti-D immunoglobulin) is typically administered to prevent Rh sensitization in Rh-negative women who might be exposed to Rh-positive fetal blood. It is given to protect against the formation of anti-Rh antibodies that could affect future pregnancies. The vaccine is not given after an intrauterine transfusion because this procedure is performed to treat severe fetal anemia in cases where the mother is Rh-positive or the indirect Coombs test (ICT) is positive, indicating that the mother has already been sensitized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Amniocentesis at 16 weeks:</strong> Anti-D vaccine is given after amniocentesis to prevent Rh sensitization, as the procedure can cause fetal blood to mix with maternal blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual removal of placenta:</strong> Anti-D vaccine is administered after manual removal of the placenta to prevent sensitization, as this procedure can result in significant feto-maternal hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. MTP at 63 days:</strong> Anti-D vaccine is given after medical termination of pregnancy (MTP) to prevent Rh sensitization if the mother is Rh-negative and the fetus is Rh-positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-D vaccine is not given after intrauterine transfusion, as this procedure is used to treat severe fetal anemia and does not require further prophylaxis against Rh sensitization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 919, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5693,
      "choices": [
        {
          "id": 22744,
          "text": "<p><span style=\"font-size:12pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 22745,
          "text": "<p><span style=\"font-size:12pt;\">Meningitis</span></p>"
        },
        {
          "id": 22746,
          "text": "<p><span style=\"font-size:12pt;\">Acute migraine</span></p>"
        },
        {
          "id": 22747,
          "text": "<p><span style=\"font-size:12pt;\">Cortical vein thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A lady was discharged after a normal vaginal delivery. On the third day she came back with fever, tachycardia and seizures. Fundus showed papilledema with no focal deficits. Diagnosis is?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q1026385",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768665,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Cortical vein thrombosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical situation likely suggests Cortical Vein Thrombosis.</span></li><li><span style=\"font-size:12pt;\">Cortical Vein thrombosis</span><ul><li><span style=\"font-size:12pt;\">Risk factors:</span><ul><li><span style=\"font-size:12pt;\">Pregnancy and puerperium</span></li><li><span style=\"font-size:12pt;\">Oral contraceptives</span></li><li><span style=\"font-size:12pt;\">Pro thrombotic conditions</span></li></ul></li><li><span style=\"font-size:12pt;\">Clinical presentation</span><ul><li><span style=\"font-size:12pt;\">Highly variable</span></li><li><span style=\"font-size:12pt;\">Headache is the most common symptom.</span></li><li><span style=\"font-size:12pt;\">With or without</span></li><li><span style=\"font-size:12pt;\">Vomiting</span></li><li><span style=\"font-size:12pt;\">Papilledema</span></li><li><span style=\"font-size:12pt;\">Focal deficits</span></li></ul></li><li><span style=\"font-size:12pt;\">Investigation</span><ul><li><span style=\"font-size:12pt;\">Brain MRI with MR venography - most sensitive</span></li><li><span style=\"font-size:12pt;\">CT - normal in 30 % of cases.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Subarachnoid hemorrhage:</strong> Subarachnoid hemorrhage unlikely as there are no focal deficits</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Meningitis:</strong> Meningitis would have presented with neck rigidity / photophobia and early papilledema goes against acute meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Acute Migraine:</strong> Acute Migraine does not present with seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cortical/ Cerebral vein thrombosis should be thought of in a patient with headache and seizures/ other neurological deficits following delivery</strong></span></li></ul>",
      "correct_choice_id": 22747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5768,
      "choices": [
        {
          "id": 23043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">500</span></span></span></p>"
        },
        {
          "id": 23044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300</span></span></span></p>"
        },
        {
          "id": 23045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue same diet</span></span></span></p>"
        },
        {
          "id": 23046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">600</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant lady of 49 kg is in her first trimester. What are her additional calorie requirements in this trimester?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q5419551",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768916,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Continue same diet</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy requires an additional 80,000 Kcal; mostly in the latter half. During the first trimester, there is no need for additional calories. The caloric increase is recommended as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0 Kcal in 1st trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">340 Kcal in 2nd trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">452 Kcal in 3rd trimester</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this question, extra calories in the 1st trimester are asked, so the answer will be no additional requirement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There are no additional calorie requirements in the first trimester of pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Page no 487, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5766,
      "choices": [
        {
          "id": 23035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
        },
        {
          "id": 23036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone</span></span></span></p>"
        },
        {
          "id": 23037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></span></p>"
        },
        {
          "id": 23038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bupivacaine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug must always be available for emergency use in labor ward if a patient is on opioid analgesic?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9671550",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768915,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Naloxone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone is a narcotic antagonist capable of reversing respiratory depression induced by opioid narcotics. It acts by displacing the narcotic from specific receptors in the central nervous system, thus reversing the effects of the opioid, including respiratory depression. This makes it an essential drug to have on hand in the labor ward when a patient is receiving opioid analgesics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fentanyl:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an opioid analgesic used for pain management, not for reversing opioid effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Morphine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is another opioid analgesic and would not be used to counteract the effects of other opioids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bupivacaine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a local anesthetic used for epidural anesthesia, not an opioid antagonist.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone must always be available in the labor ward for emergency use when a patient is on opioid analgesic to promptly reverse opioid-induced respiratory depression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 546, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5881,
      "choices": [
        {
          "id": 23494,
          "text": "<p><span style=\"font-size:12pt;\">Cervical length</span></p>"
        },
        {
          "id": 23495,
          "text": "<p><span style=\"font-size:12pt;\">Type of maternal pelvis</span></p>"
        },
        {
          "id": 23496,
          "text": "<p><span style=\"font-size:12pt;\">Cervical position</span></p>"
        },
        {
          "id": 23497,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation of cervix</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a component of the Bishop score?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q4405097",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768890,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Type of maternal pelvis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Bishop Score</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.&nbsp;</span></li><li><span style=\"font-size:12pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).&nbsp;</span></li><li><span style=\"font-size:12pt;\">The 5 components of the Modified Bishop score are:</span><ol><li><span style=\"font-size:12pt;\">Cervical Dilatation</span></li><li><span style=\"font-size:12pt;\">Cervical length</span></li><li><span style=\"font-size:12pt;\">Cervical consistency</span></li><li><span style=\"font-size:12pt;\">Cervical Position</span></li><li><span style=\"font-size:12pt;\">Station of the presenting part</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Easy to remember Mnemonic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">B – Bishop</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">I – Effacement</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">S – Station of presenting part</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">H – Hard/ soft (consistency)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">O – Os dilatation (cervical dilatation)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">P – Position of the cervix</span><br>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-226.jpg\" alt=\"\" width=\"900\" height=\"473\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cervical length</strong>: This is a component of the Modified Bishop score, measuring the length of the cervix in centimeters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cervical position</strong>: This is a component of the Bishop score, assessing the position of the cervix relative to the vaginal canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation of cervix</strong>: This is a component of the Bishop score, measuring the extent to which the cervix has opened.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Type of maternal pelvis is not a component of the Bishop score.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 600, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5802,
      "choices": [
        {
          "id": 23179,
          "text": "<p><span style=\"font-size:12pt;\">Pituitary dysfunction</span></p>"
        },
        {
          "id": 23180,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian dysfunction</span></p>"
        },
        {
          "id": 23181,
          "text": "<p><span style=\"font-size:12pt;\">First pregnancy</span></p>"
        },
        {
          "id": 23182,
          "text": "<p><span style=\"font-size:12pt;\">Uterine synechiae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A young female has history of a induced abortion at 11 weeks. She has had amenorrhea since then. Her FSH now is 6 mlU/ml. Which of the following can be a cause for her amenorrhea?&nbsp;(INICET MAY 2018)</span></p>",
      "unique_key": "Q4084365",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768709,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Uterine synechiae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a spontaneous abortion and subsequent dilation and curettage (D&amp;C) is typically due to intrauterine adhesions, also known as Asherman syndrome.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Uterine Synechiae (Asherman Syndrome):</strong> This condition involves the formation of scar tissue within the uterine cavity, leading to amenorrhea or menstrual abnormalities. It commonly occurs after uterine surgeries like D&amp;C.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Diagnosis:</strong> Hysteroscopy is the gold standard for diagnosing Asherman syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:</strong> Hysteroscopic adhesiolysis is the treatment to remove the adhesions and restore normal uterine cavity function.</span></li></ul></li></ul><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pituitary dysfunction:</strong> This would typically be associated with abnormal levels of pituitary hormones, including FSH. The normal FSH level (6 mIU/ml) suggests that pituitary function is intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ovarian dysfunction:</strong> This condition would generally present with elevated or depressed levels of FSH and other ovarian hormones. The normal FSH level suggests that ovarian function is likely normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. First pregnancy:</strong> In pregnancy, FSH levels are very low (&lt;0.1 mIU/ml). The FSH level of 6 mIU/ml makes this an unlikely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a history of spontaneous abortion and D&amp;C is usually due to intrauterine adhesions (Asherman syndrome), diagnosed by hysteroscopy and treated with hysteroscopic adhesiolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 459, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20501,
      "choices": [
        {
          "id": 81966,
          "text": "<p><span style=\"font-size:12pt;\">Increased intracranial pressure</span></p>"
        },
        {
          "id": 81967,
          "text": "<p><span style=\"font-size:12pt;\">IVC compression</span></p>"
        },
        {
          "id": 81968,
          "text": "<p><span style=\"font-size:12pt;\">Heavy meals</span></p>"
        },
        {
          "id": 81969,
          "text": "<p><span style=\"font-size:12pt;\">Excessive venous pooling at the feet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 36 weeks of gestation presents to you with complaints of feeling light-headedness and dizziness when she lies on her back and feels relieved if she lies on her side or when walks. What is the most likely reason behind this?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q2892728",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768920,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) IVC compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms of light-headedness and dizziness that the pregnant woman experiences when lying on her back, which are relieved by lying on her side or walking, are indicative of inferior vena cava (IVC) compression. In the supine position during late pregnancy, the gravid uterus compresses the IVC, which can decrease venous return to the heart. This condition, known as supine hypotensive syndrome, leads to reduced cardiac output and can cause symptoms such as dizziness, light-headedness, and a decreased supply of oxygen and nutrients to vital organs.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Supine Hypotensive Syndrome:</strong> This occurs when the enlarged uterus compresses the IVC, reducing venous return to the heart, leading to symptoms like dizziness and light-headedness.</span></li><li><span style=\"font-size:12pt;\"><strong>Relief by changing position:</strong> Symptoms are relieved when the woman lies on her side or walks because these positions alleviate the pressure on the IVC, improving venous return and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased intracranial pressure:</strong> This would present with symptoms such as headache, vomiting, visual disturbances, and altered mental status, not positional dizziness relieved by lying on the side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Heavy meals:</strong> While heavy meals can cause discomfort, they are unlikely to cause the specific positional symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Excessive venous pooling at the feet:</strong> This might cause symptoms such as swelling and discomfort in the legs but not the specific positional dizziness described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Inferior vena cava compression by the gravid uterus in late pregnancy can cause supine hypotensive syndrome, leading to light-headedness and dizziness when lying on the back, which is relieved by lying on the side or walking.</span></p>",
      "correct_choice_id": 81967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5854,
      "choices": [
        {
          "id": 23386,
          "text": "<p><span style=\"font-size:12pt;\">Gardasil</span></p>"
        },
        {
          "id": 23387,
          "text": "<p><span style=\"font-size:12pt;\">Biovac</span></p>"
        },
        {
          "id": 23388,
          "text": "<p><span style=\"font-size:12pt;\">Rabivac</span></p>"
        },
        {
          "id": 23389,
          "text": "<p><span style=\"font-size:12pt;\">Tvac</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old unmarried female has come to the gynae OPD for cervical cancer vaccination. Which is preferred?</span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q3408412",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768883,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gardasil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for cervical cancer prevention. It is a quadrivalent HPV vaccine that provides protection against four serotypes of the Human Papillomavirus (HPV): 6, 11, 16, and 18.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>HPV Serotypes Covered by Gardasil:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>6 and 11:</strong> These types are associated with anogenital warts.</span></li><li><span style=\"font-size:12pt;\"><strong>16 and 18:</strong> These types are linked to cervical cancer and other HPV-related cancers.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is administered as an intramuscular injection with a recommended schedule of three doses (0, 2, and 6 months).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Available HPV Vaccines:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Cervarix (Bivalent):</strong> Covers HPV serotypes 16 and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil (Quadrivalent):</strong> Covers HPV serotypes 6, 11, 16, and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil 9 (Nonavalent or HPV9):</strong> Covers HPV serotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervavac (India’s indigenous HPV vaccine):</strong> Quadrivalent, covers serotypes 6, 11, 16, and 18.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Biovac:</strong> This is a vaccine for Hepatitis A, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rabivac:</strong> This is a rabies vaccine for animals, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tvac:</strong> This is a tetanus vaccine, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for preventing cervical cancer and related HPV diseases, covering serotypes 6, 11, 16, and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)</u></strong></span></a></p>",
      "correct_choice_id": 23386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5885,
      "choices": [
        {
          "id": 23510,
          "text": "<p><span style=\"font-size:12pt;\">Gently replace the cord inside the vagina</span></p>"
        },
        {
          "id": 23511,
          "text": "<p><span style=\"font-size:12pt;\">Inform the doctor and shift to OT</span></p>"
        },
        {
          "id": 23512,
          "text": "<p><span style=\"font-size:12pt;\">Put her in Trendelenburg position</span></p>"
        },
        {
          "id": 23513,
          "text": "<p><span style=\"font-size:12pt;\">Do vaginal examination and find the fetal presentation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A midwife is examining a pregnant woman in labour when she noticed that there is cord prolapse. What should be the next immediate step of management?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q6940306",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768894,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Put her in Trendelenburg position</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cord prolapse is an obstetric emergency where the umbilical cord slips ahead of the presenting part of the fetus in the birth canal, leading to compression of the cord. This compression can restrict blood flow and oxygen to the fetus, causing fetal distress or hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The immediate management of cord prolapse includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Relieving pressure off the cord</strong>: This is crucial to prevent fetal hypoxia. This can be achieved by positioning the patient in a way that minimizes pressure on the cord.</span></li><li><span style=\"font-size:12pt;\"><strong>Trendelenburg position</strong>: This position involves tilting the patient’s body with the head down and the pelvis up. This helps to shift the fetal presenting part off the prolapsed cord and relieves compression.</span></li><li><span style=\"font-size:12pt;\"><strong>Left lateral position or All-fours position</strong>: Alternative positions can also help in relieving pressure on the cord.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While preparing for an emergency cesarean section (LSCS) to deliver the fetus urgently, these positions and techniques are used to temporarily alleviate the pressure on the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Gently replace the cord inside the vagina</strong>: Attempting to reposition the cord is not recommended as it can cause further damage or spasm of the vessels in the cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Inform the doctor and shift to OT</strong>: While informing the doctor and preparing for cesarean delivery is necessary, immediate steps to relieve cord compression should be taken first.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Do vaginal examination and find the fetal presentation</strong>: This may be done, but the primary focus should be on relieving the pressure on the cord immediately to prevent fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the case of cord prolapse, placing the patient in Trendelenburg position helps to relieve pressure on the prolapsed cord and is a critical step in managing the emergency until a cesarean section can be performed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1129, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5735,
      "choices": [
        {
          "id": 22912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quantity of sperms</span></span></span></p>"
        },
        {
          "id": 22913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The motility of sperms</span></span></span></p>"
        },
        {
          "id": 22914,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology of sperms</span></span></span></p>"
        },
        {
          "id": 22915,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The number of sperm</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the best parameter to assess in case of male infertility?&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q7035677",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768902,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The morphology of sperms</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology of sperms is considered the best parameter to assess male infertility. Sperm morphology refers to the size and shape of sperm, and abnormalities in these characteristics can significantly affect a man&#39;s fertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Morphology:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterization of normal sperm morphology shows improved correlation with fertilization rates during IVF cycles. A significantly decreased fertilization rate is observed when the normal morphology of the sample falls below the strict criteria of 4%.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Quantity and Number:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the quantity and number of sperms are important, they are not as critical as morphology in determining fertility potential.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm Motility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Motility is also a crucial factor, but morphology has a stronger correlation with fertilization success.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. The quantity of sperms:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Refers to the total volume of ejaculate, which is less indicative of fertility compared to morphology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The motility of sperms:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Important for fertility but not as strongly correlated with fertilization success as morphology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The number of sperm:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to the quantity, the number is important but does not correlate as closely with fertilization rates as morphology does.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sperm morphology is the most significant parameter for assessing male infertility, as it closely correlates with fertilization rates during assisted reproductive techniques like IVF.</span></span></span></p>",
      "correct_choice_id": 22914,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5757,
      "choices": [
        {
          "id": 22999,
          "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
        },
        {
          "id": 23000,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 23001,
          "text": "<p><span style=\"font-size:12pt;\">Mirena</span></p>"
        },
        {
          "id": 23002,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation and curettage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old postmenopausal lady is detected by endometrial hyperplasia with atypia what is the next step in management?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q8389891",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768911,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Hysterectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Postmenopausal women with atypical hyperplasia should be offered a total hysterectomy with bilateral salpingo-oophorectomy due to the very high risk of progression to malignancy. This approach effectively removes the source of hyperplasia and eliminates the potential for malignant transformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Progesterone:</strong> High dose Progesterones can be used to manage endometrial hyperplasia without atypia, but this is not the recommended approach for atypical hyperplasia in postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mirena:</strong> The LNG-IUS (Mirena) can be recommended for those who want to preserve fertility and for managing endometrial hyperplasia without atypia. However, it is not suitable for postmenopausal women with atypical hyperplasia due to the high risk of progression to malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation and curettage:</strong> This procedure may be used for diagnostic purposes but is not treatment for endometrial hyperplasia with atypia in postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Postmenopausal women with atypical endometrial hyperplasia should undergo a total hysterectomy with bilateral salpingo-oophorectomy due to the high risk of progression to malignancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 329, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5686,
      "choices": [
        {
          "id": 22716,
          "text": "<p><span style=\"font-size:12pt;\">G4P2 L1 A2</span></p>"
        },
        {
          "id": 22717,
          "text": "<p><span style=\"font-size:12pt;\">G4P1 A2 L1</span></p>"
        },
        {
          "id": 22718,
          "text": "<p><span style=\"font-size:12pt;\">G5PO L1 A2</span></p>"
        },
        {
          "id": 22719,
          "text": "<p><span style=\"font-size:12pt;\">G5P1 A2 L1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman came to OPD with a twin pregnancy at 10 weeks of gestation. She has a 3-year-old female child who was born at term and had 2 first trimester abortions previously. Which of the following is the correct representation of her obstetric score/formula?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q8582428",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768660,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) G4P1 A2 L1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Determining the Parity Index/ Obstetric Formula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2 formulas</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. G __ P __ L __ A ___</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</span></li><li><span style=\"font-size:12pt;\">Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</span></li><li><span style=\"font-size:12pt;\">Living (L): The total number of living children the woman has.</span></li><li><span style=\"font-size:12pt;\">Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The obstetric score here is G4P1A2L1.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is another way to write the formula.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>IMPORTANT</u>: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2.</strong></span></p>",
      "correct_choice_id": 22717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5708,
      "choices": [
        {
          "id": 22804,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxycycline</span></span></span></p>"
        },
        {
          "id": 22805,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 22806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 22807,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female came with complaints of greenish discharge per vagina and on examination she had a strawberry cervix. Which of the following is the treatment for her?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q8044187",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768668,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Metronidazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of greenish-yellow discharge and a strawberry cervix is characteristic of trichomoniasis. Trichomoniasis is a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The diagnostic feature of trichomoniasis includes the presence of motile flagellate organisms on a wet mount microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characteristic findings:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colour of discharge:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Greenish yellow</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On examination:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Strawberry cervix and vagina</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &gt;5</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis (Wet mount):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Motile flagellate organism</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The recommended treatment for trichomoniasis is metronidazole. It can be administered as a single dose of 2g or 200mg TDS for 7 days.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxycycline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used to treat various bacterial infections, including some sexually transmitted infections, but it is not the treatment of choice for trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amoxicillin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is used for bacterial infections but is not effective against trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fluconazole:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antifungal medication is used to treat candidiasis, not trichomoniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and greenish-yellow vaginal discharge are characteristic of trichomoniasis, which is treated with metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323.png\" style=\"height:447px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strawberry cervix and vagina are characteristic of Trichomoniasis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 164, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5798,
      "choices": [
        {
          "id": 23163,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, PAPP-A and lower estriol, AFP</span></p>"
        },
        {
          "id": 23164,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, Inhibin and lower estriol, AFP</span></p>"
        },
        {
          "id": 23165,
          "text": "<p><span style=\"font-size:12pt;\">Lower -CG, PAPP-A and elevated estriol, AFP</span></p>"
        },
        {
          "id": 23166,
          "text": "<p><span style=\"font-size:12pt;\">Lower B-hCG, Inhibin and elevated estriol, AFP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following changes can be seen in the quadruple screening for Down syndrome?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q8063026",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768705,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Elevated B-hCG, Inhibin and lower estriol, AFP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The triple and quadruple test is done between 15 – 21 weeks.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-152106.jpg\" alt=\"\" width=\"1000\" height=\"198\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Easy to remember</strong>: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Elevated B-hCG, PAPP-A and lower estriol, AFP:</strong> This combination is not correct as PAPP-A is not part of the quadruple test and it typically decreases in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Lower B-hCG, PAPP-A and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Lower B-hCG, Inhibin and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In Down syndrome (Trisomy 21), the quadruple test shows elevated β hCG and Inhibin A, and decreased AFP and uE3.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 863, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5807,
      "choices": [
        {
          "id": 23198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">37 weeks</span></span></span></p>"
        },
        {
          "id": 23199,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">39 weeks</span></span></span></p>"
        },
        {
          "id": 23200,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">38 weeks</span></span></span></p>"
        },
        {
          "id": 23201,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">40 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman has gestational diabetes mellitus (GDM) and her blood glucose levels are well controlled on insulin. What will be the appropriate gestational age for her delivery?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q6311856",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 39 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The appropriate timing of delivery in a pregnant woman with gestational diabetes mellitus (GDM) whose blood glucose levels are well controlled on insulin is at or after 39 weeks of gestation. This recommendation is based on the following considerations:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung Maturity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> GDM pregnancies are associated with a delay in fetal lung maturity. Routine delivery before 39 weeks is generally not recommended to avoid respiratory complications in the newborn.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of Labor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> If the patient with well-controlled GDM has not delivered spontaneously by 39 weeks, induction of labor should be scheduled at or after 39 weeks to minimize the risks associated with GDM and to ensure fetal maturity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other important points in GDM:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Avoid Past Dates:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Delivery should not be delayed beyond the expected due date to prevent complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticipate Shoulder Dystocia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is an increased risk of shoulder dystocia in infants of mothers with GDM.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylactic Cesarean Section (LSCS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Considered if the estimated fetal weight is greater than 4.5 kg to avoid complications during vaginal delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pregnant woman with well-controlled gestational diabetes mellitus (GDM) on insulin, the appropriate gestational age for delivery is at or after 39 weeks to ensure fetal lung maturity and reduce the risk of complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><a href=\"https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/National_Guidelines_for_Diagnosis_&amp;_Management_of_Gestational_Diabetes_Mellitus.pdf\" style=\"color:blue; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://nhm.gov.in/images/pdf/programmes/maternal-health/guidelines/National_Guidelines_for_Diagnosis_&amp;_Management_of_Gestational_Diabetes_Mellitus.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 23199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5690,
      "choices": [
        {
          "id": 22732,
          "text": "<p><span style=\"font-size:12pt;\">At the perineum</span></p>"
        },
        {
          "id": 22733,
          "text": "<p><span style=\"font-size:12pt;\">Just below ischial spine</span></p>"
        },
        {
          "id": 22734,
          "text": "<p><span style=\"font-size:12pt;\">Just above ischial spine</span></p>"
        },
        {
          "id": 22735,
          "text": "<p><span style=\"font-size:12pt;\">High up in the false pelvis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old lady nearing her due date has been admitted following regular contractions. The resident doctor did an examination and told the intern that the head is at +1 station. Where is the exact position of head?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q5598060",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768663,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Just below ischial spine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In obstetrics, the station of the fetal head during labor is measured relative to the ischial spines of the maternal pelvis. The ischial spines are bony landmarks that serve as reference points.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>0 Station:</strong> The presenting part of the fetus is at the level of the ischial spines.</span></li><li><span style=\"font-size:12pt;\"><strong>Positive Stations (+1 to +5):</strong> These indicate the presenting part is below the ischial spines. For example, +1 station means the presenting part is 1 cm below the ischial spines.</span></li><li><span style=\"font-size:12pt;\"><strong>Negative Stations (-1 to -5):</strong> These indicate the presenting part is above the ischial spines.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">At +1 station, the fetal head is just below the ischial spine by 1 cm.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_muEd4bX.png\" width=\"405\" height=\"273\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. At the perineum:</strong> This would indicate a more advanced station, such as +4 or +5.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Just above the ischial spine:</strong> This would be a negative station (e.g., -1 or -2).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. High up in the false pelvis:</strong> This would correspond to a much higher, negative station.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When the station of the head is described during a vaginal exam, it is with respect to the ischial spine:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The ischial spine is taken as 0 station.</span></li><li><span style=\"font-size:12pt;\">Anything above the ischial spine is denoted as a negative station (-).</span></li><li><span style=\"font-size:12pt;\">Anything below the ischial spine is denoted as a positive station (+).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 153, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5808,
      "choices": [
        {
          "id": 23202,
          "text": "<p><span style=\"font-size:12pt;\">Immediate termination</span></p>"
        },
        {
          "id": 23203,
          "text": "<p><span style=\"font-size:12pt;\">Give surfactant and wait till 36 weeks</span></p>"
        },
        {
          "id": 23204,
          "text": "<p><span style=\"font-size:12pt;\">Do Doppler everyday to check for reversion</span></p>"
        },
        {
          "id": 23205,
          "text": "<p><span style=\"font-size:12pt;\">Terminate after 37 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4566498",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768715,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Immediate termination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Absent or Reversed End-Diastolic Flow:</strong> This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Immediate Termination:</strong> For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Give surfactant and wait till 36 weeks:</strong> This is not appropriate because the immediate risk to the fetus requires prompt delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do Doppler everyday to check for reversion:</strong> Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Terminate after 37 weeks:</strong> Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2141, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5804,
      "choices": [
        {
          "id": 23187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic tubal ligation</span></span></span></p>"
        },
        {
          "id": 23188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper-T</span></span></span></p>"
        },
        {
          "id": 23189,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Implanon</span></span></span></p>"
        },
        {
          "id": 23190,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG-IUD</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an irreversible method of contraception?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q9951383",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768711,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Laparoscopic tubal ligation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraceptive methods can be classified into temporary (reversible) and permanent (irreversible) methods.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Permanent Methods (Irreversible):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic Tubal Ligation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a surgical procedure where the fallopian tubes are cut, tied, or sealed to prevent pregnancy permanently. It is considered an irreversible method of contraception as it is intended to be a permanent solution for women who do not wish to have more children.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temporary Methods (Reversible):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper-T (Intrauterine Device - IUD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A long-term but reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Implanon (Subdermal Contraceptive Implant):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A long-term reversible method that can be removed to restore fertility.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG-IUD (Levonorgestrel Intrauterine Device):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Another long-term reversible method that can be removed when pregnancy is desired.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic tubal ligation is a permanent (irreversible) method of contraception.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 611, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5746,
      "choices": [
        {
          "id": 22956,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single dose of 0.75 after 12 hrs</span></span></span></p>"
        },
        {
          "id": 22957,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22958,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22959,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For emergency contraception, a single tab of 0.75 mg of LNG was taken, it should be followed by which of the following?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9972601",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768905,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Single dose of 0.75 after 12 hrs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the 2nd dose of LNG 0.75 mg (levonorgestrel) is taken after 12 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One tablet of LNG 0.75mg should be taken within 72 hours of unprotected intercourse and another 12 hours later. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alternately, two tablets (of 0.75mg) or a single 1.5mg tablet can be taken as a single dose. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The tablets can be offered up to 72h of an act of unprotected intercourse, but the efficacy decreases with the longer coital-drug interval.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other emergency contraceptives available: </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-094530.png\" style=\"height:301px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency contraception using levonorgestrel requires a follow-up dose of 0.75 mg taken 12 hours after the initial dose to ensure efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 243, Berek and Novak&rsquo;s Gynecology 15<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5886,
      "choices": [
        {
          "id": 23514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a screening test for cervical cancer</span></span></span></p>"
        },
        {
          "id": 23515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a diagnostic test for trichomonas infection</span></span></span></p>"
        },
        {
          "id": 23516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to diagnose cancer in her genital tract</span></span></span></p>"
        },
        {
          "id": 23517,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It helps to diagnose other associated genital infections in her</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient comes with repeated infections of trichomonas vaginitis; her physician advises for a Pap smear. She asks you regarding the purpose of this test. What would be your appropriate response?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q2687156",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768895,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It is a screening test for cervical cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear is a screening test for cervical cancer.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A cervical smear is prepared using the pap test which is sent for cytological examination</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of malignant cells on Pap smear requires further evaluation with colposcopy, cervical biopsy, fractional curettage, etc.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prerequisites:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should be done prior to vaginal examination</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lubricants should not be used</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient should not be menstruating during the pap test</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal time is around ovulation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient should not have intercourse 24hrs prior to the test</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is a diagnostic test for trichomonas vaginalis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Trichomonas vaginalis is diagnosed by seeing the flagellated organism (T. vaginalis) on a vaginal smear</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It helps to diagnose cervical cancer in her genital tract</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A pap smear is specifically for cervical cancer screening and also for recurrence from the vaginal vault following hysterectomy for CIN/ cervical cancer. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It helps to diagnose other associated genital infections in her:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A pap smear can detect associated genital infections especially cervical infections but is not routinely used for this purpose</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Pap smear is a screening test for cervical cancer, used to identify abnormal cells in the cervix.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 113, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition.</span></strong></span></span></p>",
      "correct_choice_id": 23514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5809,
      "choices": [
        {
          "id": 23206,
          "text": "<p><span style=\"font-size:12pt;\">S3</span></p>"
        },
        {
          "id": 23207,
          "text": "<p><span style=\"font-size:12pt;\">S4</span></p>"
        },
        {
          "id": 23208,
          "text": "<p><span style=\"font-size:12pt;\">Fixed splitting of S2</span></p>"
        },
        {
          "id": 23209,
          "text": "<p><span style=\"font-size:12pt;\">Pericardial knock</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following heart sounds would be normal in pregnancy?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q2698408",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768716,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) S3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During pregnancy, the cardiovascular system undergoes significant changes to accommodate the increased blood volume and cardiac output required to support both the mother and the developing fetus. One of the normal physiological changes includes the presence of the S3 heart sound.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>S3 Heart Sound:</strong> The S3 sound, also known as the ventricular gallop, is due to rapid diastolic filling of the ventricles. It is commonly heard in pregnant women due to the increased blood volume and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other heart sounds mentioned are not typically considered normal in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. S4 Heart Sound:</strong> The S4 sound, or atrial gallop, is generally associated with pathological conditions such as left ventricular hypertrophy or myocardial ischemia. It is rare in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fixed Splitting of S2:</strong> Fixed splitting of the second heart sound is usually indicative of an atrial septal defect (ASD) and is not normal in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pericardial Knock:</strong> This is a sound heard in cases of constrictive pericarditis and is not a normal finding in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The S3 heart sound is considered normal during pregnancy due to the increased blood volume and rapid diastolic filling of the ventricles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 178, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5754,
      "choices": [
        {
          "id": 22987,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st stage</span></span></span></p>"
        },
        {
          "id": 22988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2nd stage</span></span></span></p>"
        },
        {
          "id": 22989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3rd stage</span></span></span></p>"
        },
        {
          "id": 22990,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4th stage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A primigravida came with 6 cm cervical dilatation and a contraction rate of 3/10 minutes. Which stage of labor is she in?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9109544",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768909,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1st stage</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient is in the 1st stage of labor, which is defined as the onset of true labor pain until the full dilation of the cervix. The 1st stage of labor can be further classified as:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latent phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cervical dilation of less than 5 cm.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active phase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cervical dilation of 5 cm or more.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Earlier, this cutoff for the active phase was considered at 4 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 2nd stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The second stage of labor begins with complete cervical dilation and ends with the delivery of the fetus. Since the cervix is not fully dilated (10 cm), the patient is not in the second stage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 3rd stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The third stage of labor is characterized by the delivery of the placenta. The patient is not in this stage as the fetus has not yet been delivered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 4th stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The fourth stage is a stage of observation for at least an hour after the full expulsion of the placenta. The patient is not in this stage as the delivery process is still ongoing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The 1st stage of labor, which involves cervical dilation from the onset of true labor pain until full dilation, is divided into latent and active phases, with the active phase beginning at 5 cm dilation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 155, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5676,
      "choices": [
        {
          "id": 22676,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10% buffered formalin</span></span></span></p>"
        },
        {
          "id": 22677,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 22678,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Air dried</span></span></span></p>"
        },
        {
          "id": 22679,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fixative for PAP smear:&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q4878922",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768655,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 95% ethyl alcohol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol. This fixative preserves the cellular detail necessary for accurate cytological evaluation by preventing cellular autolysis and degradation. The use of 95% ethyl alcohol ensures that the cells maintain their morphology, which is critical for detecting abnormalities such as dysplasia or carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% Ethyl Alcohol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the standard fixative for Pap smears, ensuring optimal preservation of cellular details.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethanol Spray:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In modern practice, an ethanol spray fixative is available, which can be conveniently used in an office setting to fix the smear immediately after it is taken.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 10% buffered formalin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This fixative is typically used for histological specimens rather than cytological smears like the Pap test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Air dried:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Air drying is not recommended for Pap smears as it can cause cellular distortion and artifacts, which complicate the interpretation of the smear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. None of the above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect as 95% ethyl alcohol is the correct fixative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol, which preserves cellular morphology necessary for accurate cytological evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 271, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5882,
      "choices": [
        {
          "id": 23498,
          "text": "<p><span style=\"font-size:12pt;\">2cm</span></p>"
        },
        {
          "id": 23499,
          "text": "<p><span style=\"font-size:12pt;\">4cm</span></p>"
        },
        {
          "id": 23500,
          "text": "<p><span style=\"font-size:12pt;\">5cm</span></p>"
        },
        {
          "id": 23501,
          "text": "<p><span style=\"font-size:12pt;\">6cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A nursing assistant posted in the obstetric care unit was asked to plot a partograph to monitor the progress of labour. After how much dilatation of the cervix, should she start plotting the graph?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q5710698",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768891,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 4cm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In the WHO modified partograph, labor ((Cervical dilatation vs time) &nbsp;is plotted on a graph and analysis includes use of action lines and alert lines.</span></li><li><span style=\"font-size:12pt;\">In the WHO modified partograph, the plotting starts in active phase (4cm)</span></li><li><span style=\"font-size:12pt;\">The alert line is plotted at a cervical dilatation rate of 1cm/h</span></li><li><span style=\"font-size:12pt;\">The action line is plotted 4h to the right of the alert line</span></li><li><span style=\"font-size:12pt;\">&nbsp;The 1<sup>st</sup> marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">The WHO modified partograph has now been replaced by the WHO labor care guide where the new definition of active labor is 5 cm so when answering a question read carefully what is asked – WHO modified partograph or WHO Labor care guide</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Plotting on the partograph should start at 4 cm cervical dilatation during the active phase of labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 152, DC Dutta’s Textbook of Obstetrics 7<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5844,
      "choices": [
        {
          "id": 23346,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole</span></span></span></p>"
        },
        {
          "id": 23347,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 23348,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clindamycin</span></span></span></p>"
        },
        {
          "id": 23349,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythromycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug of choice for treatment of pregnant woman with bacterial vaginosis?&nbsp;</span></span>(INICET MAY 2019)</p>",
      "unique_key": "Q3281891",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768718,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Metronidazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole is the drug of choice for treating bacterial vaginosis (BV) in pregnant women. This choice is based on its efficacy in addressing the anaerobic bacterial overgrowth that characterizes BV. It is generally prescribed as 200 mg three times daily for 7 days during pregnancy. While Clindamycin is also used for BV and can be an alternative, Metronidazole remains the preferred treatment due to its effectiveness and established safety profile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fluconazole:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This drug is used for the treatment of fungal infections like candidiasis, not bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Clindamycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Clindamycin is an alternative treatment for BV, especially if Metronidazole is contraindicated or not tolerated. However, Metronidazole is typically preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Erythromycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This antibiotic is generally used for various bacterial infections but is not the first choice for BV. It is not typically used for treating bacterial vaginosis in pregnant women.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323_QHDxmB9.png\" style=\"height:447px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole is the drug of choice for treating bacterial vaginosis in pregnant women.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 554, DC Dutta&rsquo;s Textbook of gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5703,
      "choices": [
        {
          "id": 22784,
          "text": "<p><span style=\"font-size:12pt;\">Estimate serum estradiol values</span></p>"
        },
        {
          "id": 22785,
          "text": "<p><span style=\"font-size:12pt;\">Give progesterone and stop after 10 days for withdrawal bleeding</span></p>"
        },
        {
          "id": 22786,
          "text": "<p><span style=\"font-size:12pt;\">Check USG for polycystic ovaries</span></p>"
        },
        {
          "id": 22787,
          "text": "<p><span style=\"font-size:12pt;\">Do a urine pregnancy test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female came with complaints of 4 months amenorrhea. Her FSH and LH were elevated above the normal value, thyroid function tests were normal. Which is the next step in management?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q8847365",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768667,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Give progesterone and stop after 10 days for withdrawal bleeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Since LH and FSH are elevated above the normal value, the possibility of a pregnancy can be ruled out as FSH and LH levels fall to very low levels in pregnancy</span></li><li><span style=\"font-size:12pt;\">The first step in evaluation of secondary amenorrhoea after ruling out pregnancy is to do a progesterone challenge test i.e. to see if she bleeds after a challenge of progesterone.</span></li><li><span style=\"font-size:12pt;\">If she bleeds, the diagnosis is anovulation like in PCOS</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Estimate serum estradiol values</strong>: Serum estradiol level measurement has no role in evaluation of secondary amenorrhoea</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Do a urine pregnancy test</strong>: FSH levels in pregnancy are very very low so pregnancy is unlikely; otherwise the most common cause of secondary amenorrhoea is pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Check USG for Polycystic ovaries</strong>: This is done if the patient bleeds following progesterone withdrawal as it determines the cause of anovular cycles</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Secondary amenorrhea is defined as a period of amenorrhoea of 6 months</span></li><li><span style=\"font-size:12pt;\">Pregnancy needs to be ruled out</span></li><li><span style=\"font-size:12pt;\">The most common cause of secondary amenorrhea after ruling out pregnancy is anovulation (PCOS) which can be determined by the progesterone withdrawal test</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 457, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5755,
      "choices": [
        {
          "id": 22991,
          "text": "<p><span style=\"font-size:12pt;\">Mayo scissors</span></p>"
        },
        {
          "id": 22992,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Curved scissors</span></p>"
        },
        {
          "id": 22993,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Suture remover</span></p>"
        },
        {
          "id": 22994,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Episiotomy scissors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the following instrument commonly used in obstetrics?&nbsp;(INICET NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/1_j5V5gW3.jpg\" alt=\"\" width=\"300\" height=\"167\"></span></p>",
      "unique_key": "Q9167408",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768910,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Episiotomy scissors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The instrument shown in the picture is an episiotomy scissors. The angulation in the scissor is designed to prevent the extension of a pelvic tear into the anal margins and to avoid obstetric anal sphincter injuries or complete perineal tears.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">An episiotomy is not given routinely. Its use should be restricted to specific situations such as:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Macrosomia:</strong> When the baby is larger than average.</span></li><li><span style=\"font-size:12pt;\"><strong>After coming head of breech:</strong> To facilitate the delivery of the head in a breech birth.</span></li><li><span style=\"font-size:12pt;\"><strong>Instrumental delivery:</strong> When tools like forceps or vacuum are used to assist in delivery.</span></li><li><span style=\"font-size:12pt;\"><strong>Shoulder dystocia:</strong> A delivery complication where the baby's shoulders get stuck.</span></li><li><span style=\"font-size:12pt;\"><strong>Rigid perineum:</strong> Often seen in primigravida, where the perineum does not stretch easily.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Mayo scissors:</strong> General-purpose surgical scissors used for cutting tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Curved scissors:</strong> Scissors with a curved blade, used for various surgical procedures but not specifically for episiotomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Suture remover:</strong> Scissors designed specifically for removing sutures, not for performing an episiotomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Episiotomy scissors are specifically designed to perform an episiotomy, which is a surgical incision made in the perineum to facilitate childbirth and prevent severe perineal tears. Their use is restricted to specific obstetric situations to avoid unnecessary complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 755 Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22994,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5753,
      "choices": [
        {
          "id": 22983,
          "text": "<p><span style=\"font-size:12pt;\">Second Pelvic grip</span></p>"
        },
        {
          "id": 22984,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Abdominal grip</span></p>"
        },
        {
          "id": 22985,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Pawlik grip</span></p>"
        },
        {
          "id": 22986,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fundal grip</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the grip in the image given below:&nbsp;(INICET NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2017-2.jpg\" alt=\"\" width=\"200\" height=\"288\"></p>",
      "unique_key": "Q5754913",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768908,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Pawlik grip</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The Leopold's third manuever is also called the Pawlik's grip.</span></li><li><span style=\"font-size:12pt;\">It is performed by grasping with the thumb and fingers, the lower portion of the maternal abdomen just above the symphysis pubis. If the presenting part is not engaged, a movable mass will be felt.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Obstetric grips (Leopold maneuvers):</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12pt;\">Fundal grip (1st Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿Lateral/umbilical grip (2nd Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿1st pelvic grip / Pawlik grip (3rd Leopold)</span></li><li><span style=\"font-size:12pt;\">2nd pelvic grip (4th Leopold)</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nwqPKkx.png\" width=\"481\" height=\"651\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Second Pelvic grip:</strong> This is incorrect. The second pelvic grip, also known as the fourth Leopold maneuver, is used to determine the degree of fetal descent and engagement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Abdominal grip:</strong> This term is not specific to any of the Leopold maneuvers and is not used in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fundal grip:</strong> This is the first Leopold maneuver, used to determine the fetal part located in the fundus of the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Pawlik grip (third Leopold maneuver) involves grasping the lower portion of the maternal abdomen just above the symphysis pubis to assess the engagement of the presenting part of the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 89-90, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22985,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5674,
      "choices": [
        {
          "id": 22668,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty</span></span></span></p>"
        },
        {
          "id": 22669,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral gonadectomy</span></span></span></p>"
        },
        {
          "id": 22670,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HRT to induce puberty</span></span></span></p>"
        },
        {
          "id": 22671,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoroplasty</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 18-year-old girl with primary amenorrhea, no breast development and Prader 3 genitalia was found to have raised FSH. Her karyotype revealed 45 X0/46 XY and an ultrasound revealed Mullerian structures with poorly visualized gonads. What would be the next line of management?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q8287417",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768654,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bilateral gonadectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient has gonadal dysgenesis with virilization (Prader 3 classification is used to describe the degree of virilization of external genitalia)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-111404.jpg\" style=\"height:922px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a Y-chromosome is identified during evaluation of primary amenorrhoea, laparoscopic prophylactic gonadectomy is recommended at the time of diagnosis to eliminate the risk of malignancy as dysgenetic gonads have a very high risk of malignancy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. HRT to induce puberty</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: After gonadectomy, then HRT can be given for secondary sexual development</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Clitoroplasty&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and<strong> Option A. vaginoplasty</strong> and other surgeries to correct the virilization may be required but the immediate next step would be to do gonadectomy</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whenever there is 46XY with primary amenorrhoea, always gonadectomy needs to be done in view of high risk of malignancy in dysgenetic gonads</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s Textbook of Reproductive Medicine </span></strong></span></span></p>",
      "correct_choice_id": 22669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5888,
      "choices": [
        {
          "id": 23522,
          "text": "<p><span style=\"font-size:12pt;\">Extend knee and dorsiflex foot</span></p>"
        },
        {
          "id": 23523,
          "text": "<p><span style=\"font-size:12pt;\">Flex knee and dorsiflex foot</span></p>"
        },
        {
          "id": 23524,
          "text": "<p><span style=\"font-size:12pt;\">Extend knee and plantar flex foot</span></p>"
        },
        {
          "id": 23525,
          "text": "<p><span style=\"font-size:12pt;\">Flex knee and plantar flex foot</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman has cramps in her legs. What will you suggest to her to relieve the pain?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q9426474",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768897,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Extend knee and dorsiflex foot</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To relieve leg cramps, the recommended technique is to:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Extend the knee</strong>: Straightening the leg helps in relieving tension and alleviating the cramp.</span></li><li><span style=\"font-size:12pt;\"><strong>Dorsiflex the foot</strong>: This involves pulling the toes towards the shin, which stretches the calf muscles and helps in reducing the cramp.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Leg cramps during pregnancy are commonly caused by factors such as deficiencies in serum calcium, elevated serum phosphorus, or increased pressure on the leg veins. Stretching and adjusting the foot position can provide immediate relief from cramps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Flex knee and dorsiflex foot</strong>: Flexing the knee while dorsiflexing the foot can help in some cases, but extending the knee is generally more effective in relieving cramp pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Extend knee and plantar flex foot</strong>: Plantar flexion (pointing the toes downward) can actually exacerbate calf cramps. Extending the knee while performing plantar flexion is not as effective for cramp relief.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Flex knee and plantar flex foot</strong>: Flexing the knee while performing plantar flexion will likely increase the cramp discomfort. This position may not provide effective relief.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To relieve leg cramps during pregnancy, extend the knee and dorsiflex the foot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://americanpregnancy.org/healthy-pregnancy/pregnancy-health-wellness/leg-cramps-during-pregnancy/\"><span style=\"font-size:12pt;\"><strong><u>https://americanpregnancy.org/healthy-pregnancy/pregnancy-health-wellness/leg-cramps-during-pregnancy</u></strong></span></a></p>",
      "correct_choice_id": 23522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5795,
      "choices": [
        {
          "id": 23151,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></p>"
        },
        {
          "id": 23152,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 19, 23, 33, 45, 58</span></p>"
        },
        {
          "id": 23153,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></p>"
        },
        {
          "id": 23154,
          "text": "<p><span style=\"font-size:12pt;\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against which of the following serotypes?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q2700026",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768673,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV Vaccines available are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Cervarix (Bivalent): 16, 18</span></li><li><span style=\"font-size:12pt;\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></li><li><span style=\"font-size:12pt;\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18,31,33,45,52,58.</span></li><li><span style=\"font-size:12pt;\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6,11,16,18</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HPV nonavalent vaccine is active against serotypes <strong>6, 11, 16, 18, 31, 33, 45, 52, 58.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule</u></strong></span></a></p>",
      "correct_choice_id": 23154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5883,
      "choices": [
        {
          "id": 23502,
          "text": "<p><span style=\"font-size:12pt;\">Pawlik's grip</span></p>"
        },
        {
          "id": 23503,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Lateral grip</span></p>"
        },
        {
          "id": 23504,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Pelvic grip</span></p>"
        },
        {
          "id": 23505,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fundal grip</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the grip shown in the image below:&nbsp;</span>(INICET MAY 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-may-2020-1.jpg\" alt=\"\" width=\"300\" height=\"318\"></p><p>&nbsp;</p>",
      "unique_key": "Q9505024",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768892,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Lateral grip</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstetric grips (Leopold manoeuvres)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12pt;\">Fundal grip (1st Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿Lateral/umbilical grip (2nd Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿1st pelvic grip /Pawlik grip (3rd Leopold)</span></li><li><span style=\"font-size:12pt;\">2nd pelvic grip (4th Leopold)</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/whatsapp-image-2023-10-02-at-122945.jpeg\" alt=\"\" width=\"500\" height=\"601\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>Lateral grip</strong>, also known as the <strong>Umbilical grip</strong> or <strong>Second Leopold's maneuver</strong>, is used to assess the position of the fetus in the uterus by palpating the sides of the maternal abdomen. This grip helps determine the location of the fetal back and limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pawlik's grip</strong>: Also known as the <strong>First pelvic grip</strong> or <strong>Third Leopold's maneuver</strong>, Pawlik's grip involves palpating the lower uterine segment to determine the fetal presenting part (e.g., whether it is a head or breech presentation).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Pelvic grip</strong>: This term is sometimes used to refer to the <strong>Second pelvic grip</strong> or <strong>Fourth Leopold's maneuver</strong>, which is used to assess the fetal engagement and the degree of descent in the pelvic cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fundal grip</strong>: This is the <strong>First Leopold's maneuver</strong>, which involves palpating the upper part of the uterus (fundus) to identify the fetal presentation (e.g., head or breech) and the lie of the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Lateral grip (Second Leopold's maneuver) is used to assess the position of the fetal back and limbs by palpating the sides of the maternal abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 89, DC Ditta’s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5739,
      "choices": [
        {
          "id": 22928,
          "text": "<p><span style=\"font-size:12pt;\">Tuboplasty</span></p>"
        },
        {
          "id": 22929,
          "text": "<p><span style=\"font-size:12pt;\">Hysteroscopy and laparoscopy-guided surgery</span></p>"
        },
        {
          "id": 22930,
          "text": "<p><span style=\"font-size:12pt;\">Hydrotubation</span></p>"
        },
        {
          "id": 22931,
          "text": "<p><span style=\"font-size:12pt;\">In-vitro fertilization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman underwent a workup for primary infertility. On hysterosalpingography, there was a bilateral cornual block. What is the next step in management?&nbsp;(INICET NOV 2017)</span></p>",
      "unique_key": "Q1328550",
      "question_audio": null,
      "question_video": null,
      "map_id": 32768903,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hysteroscopy and laparoscopy-guided surgery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cornual block, also known as proximal tubal obstruction, can be effectively managed with proximal tubal catheterization and cannulation, typically guided by hysteroscopy and laparoscopy. This method has about an 85% success rate in restoring tubal patency, making it the next logical step in management for a woman with a bilateral cornual block.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Cornual Block:</strong> Proximal tubal obstructions often require intervention to restore patency.</span></li><li><span style=\"font-size:16px;\"><strong>Hysteroscopy and Laparoscopy:</strong> These procedures allow for precise catheterization and cannulation to open the blocked tubes, leading to a high success rate.</span></li><li><span style=\"font-size:16px;\"><strong>Success Rate:</strong> Approximately 85% success in restoring tubal patency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Tuboplasty:</strong> While tuboplasty is an option for distal tubal occlusion, it is not the first-line treatment for cornual block.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hydrotubation:</strong> This procedure involves flushing the tubes with fluid but is <strong>less effective for treating</strong> cornual block compared to hysteroscopy and laparoscopy-guided surgery. Success rates are poor (15-30 %)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. In-vitro fertilization:</strong> IVF is typically considered when surgical interventions fail or are not suitable, particularly in women over 35 or those with severe tubal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cornual block in a young woman with primary infertility should be managed with hysteroscopy and laparoscopy-guided proximal tubal catheterization and cannulation to restore tubal patency before considering more invasive options like IVF.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page 1158, Berek and Novak’s Gynecology 15<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}